| Year |
Citation |
Score |
| 2024 |
Jalaleddini K, Jakimovski D, Keshavan A, McCurdy S, Leyden K, Qureshi F, Ghoreyshi A, Bergsland N, Dwyer MG, Ramanathan M, Weinstock-Guttman B, Benedict RH, Zivadinov R. Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 38234075 DOI: 10.1002/acn3.51996 |
0.556 |
|
| 2023 |
Zivadinov R, Pei J, Clayton D, Goldman DE, Winger RC, Cabatingan MS, Dwyer MG, Bergsland N. Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 38071574 DOI: 10.1136/jnnp-2023-332573 |
0.306 |
|
| 2023 |
Jakimovski D, Bittner S, Zivadinov R, Morrow SA, Benedict RH, Zipp F, Weinstock-Guttman B. Multiple sclerosis. Lancet (London, England). PMID 37949093 DOI: 10.1016/S0140-6736(23)01473-3 |
0.521 |
|
| 2023 |
Ziccardi S, Fuchs T, Dwyer MG, Zivadinov R, Hulst HE, Calabrese M, Benedict RH. Cognitive phenotypes predict response to restorative cognitive rehabilitation in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231208331. PMID 37942544 DOI: 10.1177/13524585231208331 |
0.511 |
|
| 2023 |
Barnett M, Wang D, Beadnall H, Bischof A, Brunacci D, Butzkueven H, Brown JWL, Cabezas M, Das T, Dugal T, Guilfoyle D, Klistorner A, Krieger S, Kyle K, Ly L, ... ... Zivadinov R, et al. A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis. Npj Digital Medicine. 6: 196. PMID 37857813 DOI: 10.1038/s41746-023-00940-6 |
0.364 |
|
| 2023 |
Weinstock ZL, Jaworski M, Dwyer MG, Jakimovski D, Burnham A, Wicks TR, Youngs M, Santivasci C, Cruz S, Gillies J, Covey TJ, Suchan C, Bergsland N, Weinstock-Guttman B, Zivadinov R, et al. Auditory Test of Processing Speed: Preliminary validation of a smartphone-based test of mental speed. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231199311. PMID 37842763 DOI: 10.1177/13524585231199311 |
0.472 |
|
| 2023 |
Morrow SA, Weinstock ZL, Mirmosayyeb O, Conway D, Fuchs T, Jaworski MG, Eckert S, Hojnacki DH, Dwyer MG, Zivadinov R, Weinstock-Guttman B, Benedict RHB. Detecting isolated cognitive relapses in persons with MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231201219. PMID 37776097 DOI: 10.1177/13524585231201219 |
0.301 |
|
| 2023 |
Reeves JA, Weinstock Z, Zivadinov R, Dwyer MG, Bergsland N, Salman F, Schweser F, Weinstock-Guttman B, Benedict RH, Jakimovski D. Paramagnetic rim lesions are associated with greater incidence of relapse and worse cognitive recovery following relapse. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231169466. PMID 37161349 DOI: 10.1177/13524585231169466 |
0.534 |
|
| 2023 |
Jakimovski D, Silva D, Dwyer MG, Weinstock-Guttman B, Benedict RH, Riolo J, Zivadinov R. Therapy effect on AI-derived thalamic atrophy using clinical routine MRI protocol: A longitudinal, multi-center, propensity-matched multiple sclerosis study. Multiple Sclerosis and Related Disorders. 74: 104708. PMID 37084495 DOI: 10.1016/j.msard.2023.104708 |
0.559 |
|
| 2023 |
Shi T, Browne RW, Tamaño-Blanco M, Jakimovski D, Weinstock-Guttman B, Zivadinov R, Ramanathan M, Blair RH. Metabolomic profiles in relapsing-remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up study. Metabolomics : Official Journal of the Metabolomic Society. 19: 44. PMID 37079261 DOI: 10.1007/s11306-023-02010-0 |
0.39 |
|
| 2022 |
Jakimovski D, Kavak KS, Zakalik K, Coetzee T, Gottesman M, Coyle PK, Zivadinov R, Weinstock-Guttman B. Improvement in time to multiple sclerosis diagnosis: 25-year retrospective analysis from New York State MS Consortium (NYSMSC). Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585221140271. PMID 36545928 DOI: 10.1177/13524585221140271 |
0.328 |
|
| 2022 |
Bergsland N, Dwyer MG, Jakimovski D, Tavazzi E, Benedict RH, Weinstock-Guttman B, Zivadinov R. Association of Choroid Plexus Inflammation on MRI With Clinical Disability Progression Over 5 Years in Patients With Multiple Sclerosis. Neurology. PMID 36543575 DOI: 10.1212/WNL.0000000000201608 |
0.61 |
|
| 2022 |
Siddiqui K, Browne RW, Benedict RHB, Jakimovski D, Weinstock-Guttman B, Zivadinov R, Ramanathan M. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis. Multiple Sclerosis and Related Disorders. 69: 104374. PMID 36403378 DOI: 10.1016/j.msard.2022.104374 |
0.347 |
|
| 2022 |
Veerareddy P, Dao N, Yun JW, Stokes KY, Disbrow E, Kevil CG, Cvek U, Trutschl M, Kilgore P, Ramanathan M, Zivadinov R, Alexander JS. Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses. Pathophysiology : the Official Journal of the International Society For Pathophysiology. 29: 570-582. PMID 36136071 DOI: 10.3390/pathophysiology29030044 |
0.332 |
|
| 2022 |
Zivadinov R, Jakimovski D, Ramanathan M, Benedict RH, Bergsland N, Dwyer MG, Weinstock-Guttman B. Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study. Multiple Sclerosis and Related Disorders. 67: 104094. PMID 35964555 DOI: 10.1016/j.msard.2022.104094 |
0.585 |
|
| 2022 |
Zivadinov R, Bergsland N, Jakimovski D, Weinstock-Guttman B, Benedict RHB, Riolo J, Silva D, Dwyer MG. Thalamic atrophy measured by artificial intelligence in a multicentre clinical routine real-word study is associated with disability progression. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 35902228 DOI: 10.1136/jnnp-2022-329333 |
0.339 |
|
| 2022 |
Reeves JA, Bergsland N, Dwyer MG, Wilding GE, Jakimovski D, Salman F, Sule B, Meineke N, Weinstock-Guttman B, Zivadinov R, Schweser F. Susceptibility networks reveal independent patterns of brain iron abnormalities in multiple sclerosis. Neuroimage. 261: 119503. PMID 35878723 DOI: 10.1016/j.neuroimage.2022.119503 |
0.713 |
|
| 2022 |
Sandroff BM, Motl RW, Román CAF, Wylie GR, DeLuca J, Cutter GR, Benedict RHB, Dwyer MG, Zivadinov R. Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis. Journal of Neurology. PMID 35718819 DOI: 10.1007/s00415-022-11205-9 |
0.333 |
|
| 2022 |
Jakimovski D, Zivadinov R, Pelizzari L, Dunne-Jaffe C, Browne RW, Bergsland N, Dwyer MG, Weinstock-Guttman B, Ramanathan M. Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 63: 103906. PMID 35671670 DOI: 10.1016/j.msard.2022.103906 |
0.308 |
|
| 2022 |
Carolus K, Fuchs TA, Bergsland N, Ramasamy D, Tran H, Uher T, Horakova D, Vaneckova M, Havrdova E, Benedict RHB, Zivadinov R, Dwyer MG. Time course of lesion-induced atrophy in multiple sclerosis. Journal of Neurology. PMID 35394170 DOI: 10.1007/s00415-022-11094-y |
0.325 |
|
| 2022 |
Jakimovski D, Zivadinov R. Editorial of Special Issue "Multiple Sclerosis: From Diagnostic Biomarkers to Imaging and Clinical Predictors". Diagnostics (Basel, Switzerland). 12. PMID 35204573 DOI: 10.3390/diagnostics12020482 |
0.385 |
|
| 2021 |
Lyman C, Lee D, Ferrari H, Fuchs TA, Bergsland N, Jakimovski D, Weinstock-Guttmann B, Zivadinov R, Dwyer MG. MRI-based thalamic volumetry in multiple sclerosis using FSL-FIRST: Systematic assessment of common error modes. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 34767684 DOI: 10.1111/jon.12947 |
0.32 |
|
| 2021 |
Weinstock Z, Morrow S, Conway D, Fuchs T, Wojcik C, Unverdi M, Zivadinov R, Weinstock-Guttman B, Iverson GL, Dwyer M, Benedict RH. Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211049397. PMID 34612114 DOI: 10.1177/13524585211049397 |
0.469 |
|
| 2021 |
Barnett M, Bergsland N, Weinstock-Guttman B, Butzkueven H, Kalincik T, Desmond P, Gaillard F, van Pesch V, Ozakbas S, Rojas JI, Boz C, Altintas A, Wang C, Dwyer MG, Yang S, ... ... Zivadinov R, et al. Brain atrophy and lesion burden are associated with disability progression in a multiple sclerosis real-world dataset using only T2-FLAIR: The NeuroSTREAM MSBase study. Neuroimage. Clinical. 32: 102802. PMID 34469848 DOI: 10.1016/j.nicl.2021.102802 |
0.377 |
|
| 2021 |
Jakimovski D, Dwyer MG, Bergsland N, Weinstock-Guttman B, Zivadinov R. Disease biomarkers in multiple sclerosis: current serum neurofilament light chain perspectives. Neurodegenerative Disease Management. PMID 34196596 DOI: 10.2217/nmt-2020-0058 |
0.341 |
|
| 2021 |
Fuchs TA, Dwyer MG, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Hb Benedict R, Zivadinov R. Quantifying disease pathology and predicting disease progression in multiple sclerosis with only clinical routine T2-FLAIR MRI. Neuroimage. Clinical. 31: 102705. PMID 34091352 DOI: 10.1016/j.nicl.2021.102705 |
0.357 |
|
| 2021 |
Wojcik C, Fuchs TA, Tran H, Dwyer MG, Jakimovski D, Unverdi M, Weinstock-Guttman B, Zivadinov R, Eshaghi A, Benedict RH. Staging and stratifying cognitive dysfunction in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211011390. PMID 33951975 DOI: 10.1177/13524585211011390 |
0.546 |
|
| 2021 |
Dwyer M, Lyman C, Ferrari H, Bergsland N, Fuchs TA, Jakimovski D, Schweser F, Weinstock-Guttmann B, Benedict RHB, Riolo J, Silva D, Zivadinov R. DeepGRAI (Deep Gray Rating via Artificial Intelligence): Fast, feasible, and clinically relevant thalamic atrophy measurement on clinical quality T2-FLAIR MRI in multiple sclerosis. Neuroimage. Clinical. 30: 102652. PMID 33872992 DOI: 10.1016/j.nicl.2021.102652 |
0.719 |
|
| 2021 |
Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Benedict RH, Bergsland N, Farbu E. Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 7: 2055217321992394. PMID 33623706 DOI: 10.1177/2055217321992394 |
0.516 |
|
| 2021 |
Jakimovski D, Benedict RHB, Weinstock-Guttman B, Ozel O, Fuchs TA, Lincoff N, Bergsland N, Dwyer MG, Zivadinov R. Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both? Journal of Neurology. PMID 33590339 DOI: 10.1007/s00415-021-10437-5 |
0.306 |
|
| 2021 |
Jakimovski D, Zivadinov R, Bergsland N, Ramasamy DP, Hagemeier J, Genovese AV, Hojnacki D, Weinstock-Guttman B, Dwyer MG. Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes. Neuroimage. Clinical. 29: 102554. PMID 33472143 DOI: 10.1016/j.nicl.2020.102554 |
0.323 |
|
| 2021 |
Schweser F, Hagemeier J, Dwyer MG, Bergsland N, Hametner S, Weinstock-Guttman B, Zivadinov R. Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI. Human Brain Mapping. 42: 1463-1474. PMID 33378095 DOI: 10.1002/hbm.25306 |
0.684 |
|
| 2021 |
Hildesheim FE, Ramasamy DP, Bergsland N, Jakimovski D, Dwyer MG, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. Multiple Sclerosis and Related Disorders. 47: 102653. PMID 33333417 DOI: 10.1016/j.msard.2020.102653 |
0.346 |
|
| 2021 |
Uher T, Bergsland N, Krasensky J, Dwyer MG, Andelova M, Sobisek L, Havrdova EK, Horakova D, Zivadinov R, Vaneckova M. Interpretation of Brain Volume Increase in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 31: 401-407. PMID 33314460 DOI: 10.1111/jon.12816 |
0.395 |
|
| 2020 |
Jakimovski D, Dujmic D, Hagemeier J, Ramasamy DP, Bergsland N, Dwyer MG, Eckert S, Kolb C, Lizarraga A, Hojnacki D, Weinstock-Guttman B, Zivadinov R. Late onset multiple sclerosis is associated with more severe ventricle expansion. Multiple Sclerosis and Related Disorders. 46: 102588. PMID 33296984 DOI: 10.1016/j.msard.2020.102588 |
0.375 |
|
| 2020 |
Jakimovski D, Szigeti K, Jaworski M, Ouf A, Weinstock-Guttman B, Zivadinov R, Benedict RHB. Differential Diagnosis of Cognitive Decline in Elderly Individuals With Multiple Sclerosis. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 33: 294-300. PMID 33264159 DOI: 10.1097/WNN.0000000000000252 |
0.347 |
|
| 2020 |
Morrow SA, Conway D, Fuchs T, Wojcik C, Unverdi M, Yasin F, Pol J, Eckert S, Hojnacki DH, Dwyer M, Zivadinov R, Weinstock-Guttman B, Benedict RH. Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520973618. PMID 33259273 DOI: 10.1177/1352458520973618 |
0.518 |
|
| 2020 |
Zivadinov R, Dwyer MG, Carl E, Poole EM, Cavalier S, Briassouli P, Bergsland N. Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS. Therapeutic Advances in Neurological Disorders. 13: 1756286420970754. PMID 33240397 DOI: 10.1177/1756286420970754 |
0.344 |
|
| 2020 |
Subramanian K, Utriainen D, Ramasamy DP, Sethi SK, Schweser F, Beaver J, Hagemeier J, Weinstock-Guttman B, Rajagovindan R, Zivadinov R, Haacke EM. Longitudinal Magnetic Resonance Imaging of Cerebral Microbleeds in Multiple Sclerosis Patients. Diagnostics (Basel, Switzerland). 10. PMID 33198313 DOI: 10.3390/diagnostics10110942 |
0.723 |
|
| 2020 |
Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Ramanathan M, Marchetti G, Bernardi F. Relationships Among Circulating Levels of Hemostasis Inhibitors, Chemokines, Adhesion Molecules, and MRI Characteristics in Multiple Sclerosis. Frontiers in Neurology. 11: 553616. PMID 33178104 DOI: 10.3389/fneur.2020.553616 |
0.417 |
|
| 2020 |
Bergsland N, Benedict RHB, Dwyer MG, Fuchs TA, Jakimovski D, Schweser F, Tavazzi E, Weinstock-Guttman B, Zivadinov R. Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross-Sectional Structural MRI Study. Journal of Magnetic Resonance Imaging : Jmri. e27389. PMID 33044013 DOI: 10.1002/jmri.27389 |
0.723 |
|
| 2020 |
Pol S, Liang S, Schweser F, Dhanraj R, Schubart A, Preda M, Sveinsson M, Ramasamy DP, Dwyer MG, Weckbecker G, Zivadinov R. Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE mice. Experimental Neurology. 113488. PMID 32991933 DOI: 10.1016/j.expneurol.2020.113488 |
0.635 |
|
| 2020 |
Jakimovski D, Zivadinov R, Dwyer MG, Bergsland N, Ramasamy DP, Browne RW, Weinstock-Guttman B, Ramanathan M. High density lipoprotein cholesterol and apolipoprotein A-I are associated with greater cerebral perfusion in multiple sclerosis. Journal of the Neurological Sciences. 418: 117120. PMID 32947088 DOI: 10.1016/J.Jns.2020.117120 |
0.399 |
|
| 2020 |
Jakimovski D, Bergsland N, Dwyer MG, Ramasamy DP, Ramanathan M, Weinstock-Guttman B, Zivadinov R. Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis. Diagnostics (Basel, Switzerland). 10. PMID 32932824 DOI: 10.3390/diagnostics10090685 |
0.346 |
|
| 2020 |
Zivadinov R, Schweser F, Dwyer MG, Pol S. Detection of Monocyte/Macrophage and Microglia Activation in the TMEV Model of Chronic Demyelination Using USPIO-Enhanced Ultrahigh-Field Imaging. Journal of Neuroimaging. 30: 769-778. PMID 32866329 DOI: 10.1111/Jon.12768 |
0.698 |
|
| 2020 |
Jakimovski D, Bergsland N, Dwyer MG, Traversone J, Hagemeier J, Fuchs TA, Ramasamy DP, Weinstock-Guttman B, Benedict RHB, Zivadinov R. Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients. Frontiers in Neurology. 11: 700. PMID 32765407 DOI: 10.3389/Fneur.2020.00700 |
0.467 |
|
| 2020 |
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Ramasamy DP, Hojnacki D, Lizarraga AA, Kolb C, Eckert S, Weinstock-Guttman B, Zivadinov R. Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis. American Journal of Neuroradiology. 41: 1577-1583. PMID 32763899 DOI: 10.3174/Ajnr.A6684 |
0.464 |
|
| 2020 |
McComb M, Krikheli M, Uher T, Browne RW, Srpova B, Oechtering J, Maceski AM, Tyblova M, Jakimovski D, Ramasamy DP, Bergsland N, Krasensky J, Noskova L, Fialova L, Weinstock-Guttman B, ... ... Zivadinov R, et al. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis. Journal of Clinical Lipidology. PMID 32758395 DOI: 10.1016/J.Jacl.2020.07.001 |
0.365 |
|
| 2020 |
Jaworski MG, Fuchs TA, Dwyer MG, Wojcik C, Zivadinov R, Weinstock-Guttman B, Benedict RH. Conscientiousness and deterioration in employment status in multiple sclerosis over 3 years. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520946019. PMID 32757907 DOI: 10.1177/1352458520946019 |
0.633 |
|
| 2020 |
Ashton K, Fuchs TA, Oship D, Zivadinov R, Jakimovski D, Bergsland N, Ramasamy DP, Vaughn C, Weinstock-Guttman B, Benedict RHB, Dwyer MG. Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption. Journal of Neurology. PMID 32754832 DOI: 10.1007/S00415-020-10110-3 |
0.336 |
|
| 2020 |
Jakimovski D, Vaughn CB, Eckert S, Zivadinov R, Weinstock-Guttman B. Long-term drug treatment in multiple sclerosis: safety success and concerns. Expert Opinion On Drug Safety. 19: 1121-1142. PMID 32744073 DOI: 10.1080/14740338.2020.1805430 |
0.434 |
|
| 2020 |
McComb M, Parambi R, Browne RW, Bodziak ML, Jakimovski D, Bergsland N, Maceski A, Weinstock-Guttman B, Kuhle J, Zivadinov R, Ramanathan M. Apolipoproteins AI and E are associated with neuroaxonal injury to gray matter in multiple sclerosis. Multiple Sclerosis and Related Disorders. 45: 102389. PMID 32683305 DOI: 10.1016/J.Msard.2020.102389 |
0.439 |
|
| 2020 |
Zivadinov R, Bergsland N. Cervical Spinal Cord Lesions and Atrophy versus Brain Measures in Explaining Physical Disability in Multiple Sclerosis Radiology. 296: 616-618. PMID 32579091 DOI: 10.1148/Radiol.2020202304 |
0.336 |
|
| 2020 |
Tavazzi E, Jakimovski D, Kuhle J, Hagemeier J, Ozel O, Ramanathan M, Barro C, Bergsland N, Tomic D, Kropshofer H, Leppert D, Michalak Z, Lincoff N, Dwyer MG, Benedict RHB, ... ... Zivadinov R, et al. Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32424064 DOI: 10.1212/Nxi.0000000000000737 |
0.368 |
|
| 2020 |
Jakimovski D, Ahmed MK, Vaughn CB, Zivadinov R, Weinstock-Guttman B. Tonsillectomy in multiple sclerosis patients: Retrospective, case-controlled, exploratory study. Multiple Sclerosis and Related Disorders. 42: 102131. PMID 32408150 DOI: 10.1016/J.Msard.2020.102131 |
0.469 |
|
| 2020 |
Jakimovski D, Zivadinov R, Bergsland N, Ramasamy DP, Hagemeier J, Weinstock‐Guttman B, Kolb C, Hojnacki D, Dwyer MG. Sex-Specific Differences in Life Span Brain Volumes in Multiple Sclerosis. Journal of Neuroimaging. 30: 342-350. PMID 32392376 DOI: 10.1111/Jon.12709 |
0.489 |
|
| 2020 |
Fuchs TA, Ziccardi S, Benedict RHB, Bartnik A, Kuceyeski A, Charvet LE, Oship D, Weinstock-Guttman B, Wojcik C, Hojnacki D, Kolb C, Escobar J, Campbell R, Tran HD, Bergsland N, ... ... Zivadinov R, et al. Functional Connectivity and Structural Disruption in the Default-Mode Network Predicts Cognitive Rehabilitation Outcomes in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32391981 DOI: 10.1111/Jon.12723 |
0.337 |
|
| 2020 |
Tavazzi E, Zivadinov R, Dwyer MG, Jakimovski D, Singhal T, Weinstock-Guttman B, Bergsland N. MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis. Expert Review of Neurotherapeutics. 20: 821-834. PMID 32306772 DOI: 10.1080/14737175.2020.1757435 |
0.462 |
|
| 2020 |
Uher T, Schaedelin S, Srpova B, Barro C, Bergsland N, Dwyer M, Tyblova M, Vodehnalova K, Benkert P, Oechtering J, Leppert D, Naegelin Y, Krasensky J, Vaneckova M, Havrdova EK, ... ... Zivadinov R, et al. Monitoring of radiologic disease activity by serum neurofilaments in MS Neuroimmunology and Neuroinflammation. 7. PMID 32273481 DOI: 10.1212/Nxi.0000000000000714 |
0.431 |
|
| 2020 |
Uher T, McComb M, Galkin S, Srpova B, Oechtering J, Barro C, Tyblova M, Bergsland N, Krasensky J, Dwyer M, Havrdova EK, Posova H, Vaneckova M, Zivadinov R, Horakova D, et al. Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520912379. PMID 32255388 DOI: 10.1177/1352458520912379 |
0.436 |
|
| 2020 |
Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls. Neurobiology of Aging. PMID 32147244 DOI: 10.1016/J.Neurobiolaging.2020.02.002 |
0.502 |
|
| 2020 |
Jacobsen C, Zivadinov R, Myhr KM, Dalaker TO, Dalen I, Bergsland N, Farbu E. Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 6: 2055217320902481. PMID 32064116 DOI: 10.1177/2055217320902481 |
0.389 |
|
| 2020 |
Jakimovski D, Weinstock-Guttman B, Ramanathan M, Dwyer MG, Zivadinov R. Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective. Vaccines. 8. PMID 32012815 DOI: 10.3390/Vaccines8010050 |
0.385 |
|
| 2020 |
Jakimovski D, Zivadinov R, Weinstock-Guttman B, Bergsland N, Dwyer MG, Lagana MM. Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy. Fluids and Barriers of the Cns. 17: 1-9. PMID 32000809 DOI: 10.1186/S12987-020-0172-3 |
0.467 |
|
| 2020 |
Benedict RH, Pol J, Yasin F, Hojnacki D, Kolb C, Eckert S, Tacca B, Drake A, Wojcik C, Morrow SA, Jakimovski D, Fuchs TA, Dwyer MG, Zivadinov R, Weinstock-Guttman B. Recovery of cognitive function after relapse in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519898108. PMID 31971066 DOI: 10.1177/1352458519898108 |
0.634 |
|
| 2019 |
Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM, Tomic D, Hagemeier J, Kropshofer H, Leppert D, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. Journal of Neurology. PMID 31768628 DOI: 10.1007/S00415-019-09643-Z |
0.448 |
|
| 2019 |
Karthikeyan B, Sonkawade SD, Pokharel S, Preda M, Schweser F, Zivadinov R, Kim M, Sharma UC. Tagged cine magnetic resonance imaging to quantify regional mechanical changes after acute myocardial infarction. Magnetic Resonance Imaging. PMID 31668928 DOI: 10.1016/J.Mri.2019.09.010 |
0.628 |
|
| 2019 |
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH. Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519881428. PMID 31610732 DOI: 10.1177/1352458519881428 |
0.58 |
|
| 2019 |
Bergsland N, Tavazzi E, Schweser F, Jakimovski D, Hagemeier J, Dwyer MG, Zivadinov R. Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders. Cns Drugs. 33: 1073-1086. PMID 31556017 DOI: 10.1007/S40263-019-00668-6 |
0.647 |
|
| 2019 |
Genovese AV, Hagemeier J, Bergsland N, Jakimovski D, Dwyer MG, Ramasamy DP, Lizarraga AA, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. Atrophied Brain T2 Lesion Volume at MRI Is Associated with Disability Progression and Conversion to Secondary Progressive Multiple Sclerosis Radiology. 293: 424-433. PMID 31549947 DOI: 10.1148/Radiol.2019190306 |
0.469 |
|
| 2019 |
Zivadinov R, Ramanathan M, Hagemeier J, Bergsland N, Ramasamy DP, Durfee J, Kolb C, Weinstock-Guttman B. Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis. Multiple Sclerosis and Related Disorders. 36: 101388. PMID 31525628 DOI: 10.1016/J.Msard.2019.101388 |
0.475 |
|
| 2019 |
Jakimovski D, Zivadinov R, Pelizzari L, Browne RW, Weinstock-Guttman B, Ramanathan M. Lipoprotein(a) Levels Are Associated with the Size of Extracranial Arteries in Multiple Sclerosis. Journal of Vascular Research. 1-8. PMID 31487715 DOI: 10.1159/000502115 |
0.412 |
|
| 2019 |
Fuchs TA, Benedict RHB, Bartnik A, Choudhery S, Li X, Mallory M, Oship D, Yasin F, Ashton K, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG. Preserved network functional connectivity underlies cognitive reserve in multiple sclerosis. Human Brain Mapping. PMID 31444887 DOI: 10.1002/Hbm.24768 |
0.355 |
|
| 2019 |
Jakimovski D, Kuhle J, Ramanathan M, Barro C, Tomic D, Hagemeier J, Kropshofer H, Bergsland N, Leppert D, Dwyer MG, Michalak Z, Benedict RHB, Weinstock-Guttman B, Zivadinov R. Serum neurofilament light chain levels associations with gray matter pathology: a 5-year longitudinal study. Annals of Clinical and Translational Neurology. PMID 31437387 DOI: 10.1002/Acn3.50872 |
0.421 |
|
| 2019 |
Ziliotto N, Zivadinov R, Baroni M, Marchetti G, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Straudi S, Manfredini F, Ramanathan M, Bernardi F. Plasma levels of protein C pathway proteins and brain MRI volumes in multiple sclerosis. European Journal of Neurology. PMID 31408242 DOI: 10.1111/Ene.14058 |
0.426 |
|
| 2019 |
Murali N, Browne RW, Fellows Maxwell K, Bodziak ML, Jakimovski D, Hagemeier J, Bergsland N, Weinstock-Guttman B, Zivadinov R, Ramanathan M. Cholesterol and Neurodegeneration: Longitudinal Changes in Serum Cholesterol Biomarkers Are Associated with New Lesions and Gray Matter Atrophy in Multiple Sclerosis Over 5-years Follow-up. European Journal of Neurology. PMID 31369181 DOI: 10.1111/Ene.14055 |
0.351 |
|
| 2019 |
Browne RW, Jakimovski D, Ziliotto N, Kuhle J, Bernardi F, Weinstock-Guttman B, Zivadinov R, Ramanathan M. High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? Journal of Clinical Lipidology. PMID 31307953 DOI: 10.1016/J.Jacl.2019.06.003 |
0.388 |
|
| 2019 |
Zivadinov R, Bergsland N, Hagemeier J, Ramasamy DP, Dwyer MG, Schweser F, Kolb C, Weinstock-Guttman B, Hojnacki D. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS Neurology. 93. PMID 31285398 DOI: 10.1212/Wnl.0000000000007892 |
0.76 |
|
| 2019 |
Dwyer MG, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Barnett MH, Wang C, Tomic D, Silva D, Zivadinov R. Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 31259467 DOI: 10.1111/Jon.12650 |
0.394 |
|
| 2019 |
Fuchs TA, Ziccardi S, Dwyer MG, Charvet LE, Bartnik A, Campbell R, Escobar J, Hojnacki D, Kolb C, Oship D, Pol J, Shaw MT, Wojcik C, Yasin F, Weinstock-Guttman B, ... Zivadinov R, et al. Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study. Multiple Sclerosis and Related Disorders. 34: 103-111. PMID 31254960 DOI: 10.1016/J.Msard.2019.06.026 |
0.358 |
|
| 2019 |
Zivadinov R, Dwyer MG. Network Dynamics and Cognitive Impairment in Multiple Sclerosis: Functional MRI–based Decoupling of Complex Relationships Radiology. 292: 458-459. PMID 31237815 DOI: 10.1148/Radiol.2019191125 |
0.336 |
|
| 2019 |
Fuchs TA, Benedict RH, Wilding G, Wojcik C, Jakimovski D, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zivadinov R, Dwyer MG. Trait Conscientiousness predicts rate of brain atrophy in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519858605. PMID 31219390 DOI: 10.1177/1352458519858605 |
0.566 |
|
| 2019 |
Jakimovski D, Topolski M, Kimura K, Pandya V, Weinstock-Guttman B, Zivadinov R. Decrease in secondary neck vessels in multiple sclerosis: A 5-year longitudinal magnetic resonance angiography study. Current Neurovascular Research. PMID 31195944 DOI: 10.2174/1567202616666190612111127 |
0.381 |
|
| 2019 |
Gandhi S, Marr K, Mancini M, Caprio MG, Jakimovski D, Chandra A, Hagemeier J, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years. Bmc Neurology. 19: 121. PMID 31185944 DOI: 10.1186/S12883-019-1350-2 |
0.431 |
|
| 2019 |
Bergsland N, Zivadinov R, Schweser F, Hagemeier J, Lichter D, Guttuso T. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease Movement Disorders. 34: 1006-1013. PMID 31180615 DOI: 10.1002/Mds.27730 |
0.658 |
|
| 2019 |
Jakimovski D, Weinstock-Guttman B, Roy S, Jaworski M, Hancock L, Nizinski A, Srinivasan P, Fuchs TA, Szigeti K, Zivadinov R, Benedict RHB. Cognitive Profiles of Aging in Multiple Sclerosis. Frontiers in Aging Neuroscience. 11: 105. PMID 31133845 DOI: 10.3389/Fnagi.2019.00105 |
0.458 |
|
| 2019 |
Jakimovski D, Guan Y, Ramanathan M, Weinstock-Guttman B, Zivadinov R. Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings. Neurodegenerative Disease Management. PMID 31116081 DOI: 10.2217/Nmt-2018-0046 |
0.435 |
|
| 2019 |
Fellows Maxwell K, Bhattacharya S, Bodziak ML, Jakimovski D, Hagemeier J, Browne RW, Weinstock-Guttman B, Zivadinov R, Ramanathan M. Oxysterols and Apolipoproteins in Multiple Sclerosis: A 5-year Follow-up Study. Journal of Lipid Research. PMID 31085627 DOI: 10.1194/Jlr.M089664 |
0.468 |
|
| 2019 |
Yun JW, Cvek U, Kilgore PCSR, Tsunoda I, Omura S, Sato F, Zivadinov R, Ramanathan M, Minagar A, Alexander JS. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis. Life Sciences. PMID 31082401 DOI: 10.1016/J.Lfs.2019.05.021 |
0.443 |
|
| 2019 |
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Carl E, Hojnacki D, Kolb C, Weinstock‐Guttman B, Zivadinov R. Aging and Brain Atrophy in Multiple Sclerosis. Journal of Neuroimaging. 29: 527-535. PMID 31074192 DOI: 10.1111/Jon.12625 |
0.469 |
|
| 2019 |
Ziliotto N, Bernardi F, Jakimovski D, Zivadinov R. Coagulation Pathways in Neurological Diseases: Multiple Sclerosis. Frontiers in Neurology. 10: 409. PMID 31068896 DOI: 10.3389/Fneur.2019.00409 |
0.454 |
|
| 2019 |
Gupta S, Fellows K, Weinstock-Guttman B, Hagemeier J, Zivadinov R, Ramanathan M. Marijuana Use by Patients with Multiple Sclerosis. International Journal of Ms Care. 21: 57-62. PMID 31049035 DOI: 10.7224/1537-2073.2017-112 |
0.426 |
|
| 2019 |
Jakimovski D, Topolski M, Genovese AV, Weinstock-Guttman B, Zivadinov R. Vascular aspects of multiple sclerosis: emphasis on perfusion and cardiovascular comorbidities. Expert Review of Neurotherapeutics. 19: 445-458. PMID 31003583 DOI: 10.1080/14737175.2019.1610394 |
0.454 |
|
| 2019 |
Vaughn CB, Jakimovski D, Kavak KS, Ramanathan M, Benedict RHB, Zivadinov R, Weinstock-Guttman B. Epidemiology and treatment of multiple sclerosis in elderly populations. Nature Reviews. Neurology. PMID 31000816 DOI: 10.1038/S41582-019-0183-3 |
0.446 |
|
| 2019 |
Deshpande HU, Mellis AM, Lisinski JM, Stein JS, Koffarnus MN, Paluch R, Schweser F, Zivadinov R, LaConte SM, Epstein LH, Bickel WK. Reinforcer pathology: Common neural substrates for delay discounting and snack purchasing in prediabetics. Brain and Cognition. 132: 80-88. PMID 30933707 DOI: 10.1016/J.Bandc.2019.03.003 |
0.627 |
|
| 2019 |
Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B, Zivadinov R. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study American Journal of Neuroradiology. 40: 620-625. PMID 30872420 DOI: 10.3174/Ajnr.A6011 |
0.492 |
|
| 2019 |
Zivadinov R, Bergsland N, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Lizarraga AA, Kolb C, Hojnacki D, Weinstock-Guttman B. Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study. Journal of Clinical Medicine. 8: 344. PMID 30870983 DOI: 10.3390/Jcm8030344 |
0.476 |
|
| 2019 |
Zivadinov R, Horakova D, Bergsland N, Hagemeier J, Ramasamy DP, Uher T, Vaneckova M, Havrdova E, Dwyer MG. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS. American Journal of Neuroradiology. 40: 446-452. PMID 30819766 DOI: 10.3174/Ajnr.A5987 |
0.431 |
|
| 2019 |
Jakimovski D, Weinstock-Guttman B, Gandhi S, Guan Y, Hagemeier J, Ramasamy DP, Fuchs TA, Browne RW, Bergsland N, Dwyer MG, Ramanathan M, Zivadinov R. Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study. Journal of Neurology. PMID 30758665 DOI: 10.1007/S00415-019-09208-0 |
0.461 |
|
| 2019 |
Jakimovski D, Ramanathan M, Weinstock-Guttman B, Bergsland N, Ramasamay DP, Carl E, Dwyer MG, Zivadinov R. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458519828667. PMID 30755085 DOI: 10.1177/1352458519828667 |
0.47 |
|
| 2019 |
Zivadinov R, Kresa-Reahl K, Weinstock-Guttman B, Edwards K, Burudpakdee C, Bergsland N, Dwyer MG, Khatri B, Thangavelu K, Chavin J, Mandel M, Cohan S. Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study. Journal of Comparative Effectiveness Research. PMID 30754997 DOI: 10.2217/Cer-2018-0135 |
0.376 |
|
| 2019 |
Pol S, Schweser F, Bertolino N, Preda M, Sveinsson M, Sudyn M, Babek N, Zivadinov R. Characterization of leptomeningeal inflammation in rodent experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis. Experimental Neurology. 314: 82-90. PMID 30684521 DOI: 10.1016/J.Expneurol.2019.01.013 |
0.798 |
|
| 2019 |
Jakimovski D, Benedict RH, Marr K, Gandhi S, Bergsland N, Weinstock-Guttman B, Zivadinov R. Lower total cerebral arterial flow contributes to cognitive performance in multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518819608. PMID 30625030 DOI: 10.1177/1352458518819608 |
0.637 |
|
| 2019 |
Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RH. Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518820272. PMID 30615562 DOI: 10.1177/1352458518820272 |
0.629 |
|
| 2019 |
Guan Y, Jakimovski D, Ramanathan M, Weinstock-Guttman B, Zivadinov R. The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to imaging. Neural Regeneration Research. 14: 373-386. PMID 30539801 DOI: 10.4103/1673-5374.245462 |
0.458 |
|
| 2019 |
Taege Y, Hagemeier J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Schweser F. Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R2* - A pilot study in patients with multiple sclerosis and normal controls. Neuroimage. 186: 308-320. PMID 30445148 DOI: 10.1016/J.Neuroimage.2018.11.011 |
0.694 |
|
| 2019 |
Pol S, Sveinsson M, Sudyn M, Babek N, Siebert D, Bertolino N, Modica CM, Preda M, Schweser F, Zivadinov R. Teriflunomide's Effect on Glia in Experimental Demyelinating Disease: A Neuroimaging and Histologic Study. Journal of Neuroimaging. 29: 52-61. PMID 30232810 DOI: 10.1111/Jon.12561 |
0.778 |
|
| 2019 |
Jakimovski D, Laganà MM, Topolski M, Kimura K, Pandya V, Bergsland N, Weinstock-Guttman B, Zivadinov R. Decrease in size of secondary neck vessels and cerebral aqueduct enlargement in multiple sclerosis: a 5-year longitudinal MRI study Veins and Lymphatics. DOI: 10.4081/Vl.2019.8440 |
0.389 |
|
| 2019 |
Laganà MM, Jakimovski D, Bergsland N, Zivadinov R. Measuring Aqueduct of Sylvius cerebrospinal fluid flow in multiple sclerosis using different software packages Veins and Lymphatics. DOI: 10.4081/Vl.2019.8428 |
0.314 |
|
| 2018 |
Zivadinov R, Bergsland N, Dwyer MG. Atrophied brain lesion volume, a magnetic resonance imaging biomarker for monitoring neurodegenerative changes in multiple sclerosis. Quantitative Imaging in Medicine and Surgery. 8: 979-983. PMID 30598875 DOI: 10.21037/Qims.2018.11.01 |
0.461 |
|
| 2018 |
Moore JJ, Massey JC, Ford CD, Khoo ML, Zaunders JJ, Hendrawan K, Barnett Y, Barnett MH, Kyle KA, Zivadinov R, Ma KC, Milliken ST, Sutton IJ, Ma DDF. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 30538138 DOI: 10.1136/Jnnp-2018-319446 |
0.38 |
|
| 2018 |
Vaughn CB, Kavak KS, Dwyer MG, Bushra A, Nadeem M, Cookfair DL, Ramanathan M, Benedict RH, Zivadinov R, Goodman A, Krupp L, Motl RW, Weinstock-Guttman B. Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518816619. PMID 30507270 DOI: 10.1177/1352458518816619 |
0.569 |
|
| 2018 |
Ghione E, Bergsland N, Dwyer MG, Hagemeier J, Jakimovski D, Paunkoski I, Ramasamy DP, Silva D, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine. American Journal of Neuroradiology. 39: 2237-2242. PMID 30467212 DOI: 10.3174/Ajnr.A5876 |
0.451 |
|
| 2018 |
Fuchs TA, Vaughn CB, Benedict RHB, Weinstock-Guttman B, Choudhery S, Carolus K, Rooney P, Ashton K, P Ramasamy D, Jakimovski D, Zivadinov R, Dwyer MG. Lower self-report fatigue in multiple sclerosis is associated with localized white matter tract disruption between amygdala, temporal pole, insula, and other connected structures. Multiple Sclerosis and Related Disorders. 27: 298-304. PMID 30453198 DOI: 10.1016/J.Msard.2018.11.005 |
0.386 |
|
| 2018 |
Ziliotto N, Zivadinov R, Jakimovski D, Baroni M, Tisato V, Secchiero P, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Bernardi F, Ramanathan M, Marchetti G. Plasma levels of soluble NCAM in multiple sclerosis. Journal of the Neurological Sciences. 396: 36-41. PMID 30412901 DOI: 10.1016/J.Jns.2018.10.023 |
0.477 |
|
| 2018 |
Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B. Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders. 27: 65-73. PMID 30342416 DOI: 10.1016/J.Msard.2018.09.037 |
0.42 |
|
| 2018 |
Schweser F, Zivadinov R. Quantitative susceptibility mapping (QSM) with an extended physical model for MRI frequency contrast in the brain: a proof-of-concept of quantitative susceptibility and residual (QUASAR) mapping. Nmr in Biomedicine. 31. PMID 30246892 DOI: 10.1002/Nbm.3999 |
0.65 |
|
| 2018 |
Jakimovski D, Weinstock-Guttman B, Hagemeier J, Vaughn CB, Kavak KS, Gandhi S, Bennett SE, Fuchs TA, Bergsland N, Dwyer MG, Benedict RHB, Zivadinov R. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage. Journal of the Neurological Sciences. 393: 128-134. PMID 30165291 DOI: 10.1016/J.Jns.2018.08.020 |
0.481 |
|
| 2018 |
Jakimovski D, Topolski M, Kimura K, Marr K, Gandhi S, Ramasamy DP, Bergsland N, Hagemeier J, Weinstock-Guttman B, Zivadinov R. Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena? Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. PMID 30120624 DOI: 10.1007/S10286-018-0555-6 |
0.491 |
|
| 2018 |
Jakimovski D, Gandhi S, Paunkoski I, Bergsland N, Hagemeier J, Ramasamy DP, Hojnacki D, Kolb C, Benedict RH, Weinstock-Guttman B, Zivadinov R. Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study. European Journal of Neurology. PMID 30103277 DOI: 10.1111/Ene.13769 |
0.643 |
|
| 2018 |
Zivadinov R, Polak P, Schweser F, Bergsland N, Hagemeier J, Dwyer MG, Ramasamy DP, Baker JG, Leddy JJ, Willer BS. Multimodal Imaging of Retired Professional Contact Sport Athletes Does Not Provide Evidence of Structural and Functional Brain Damage. The Journal of Head Trauma Rehabilitation. PMID 30080799 DOI: 10.1097/Htr.0000000000000422 |
0.642 |
|
| 2018 |
Willer B, Zivadinov R, Haider MN, Miecznikowski JC, Leddy JJ. A Preliminary Study of Early-Onset Dementia of Former Professional Football and Hockey Players. The Journal of Head Trauma Rehabilitation. PMID 30080796 DOI: 10.1097/Htr.0000000000000421 |
0.312 |
|
| 2018 |
Pelizzari L, Jakimovski D, Laganà MM, Bergsland N, Hagemeier J, Baselli G, Weinstock-Guttman B, Zivadinov R. Five-Year Longitudinal Study of Neck Vessel Cross-Sectional Area in Multiple Sclerosis. American Journal of Neuroradiology. 39: 1703-1709. PMID 30049718 DOI: 10.3174/Ajnr.A5738 |
0.437 |
|
| 2018 |
Zamboni P, Zivadinov R. Extracranial Veins in Multiple Sclerosis: Is There a Role for Vascular Surgery? European Journal of Vascular and Endovascular Surgery. 56: 618-621. PMID 30049571 DOI: 10.1016/J.Ejvs.2018.06.028 |
0.303 |
|
| 2018 |
Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Zamboni P, Marchetti G, Zivadinov R, Ramanathan M. Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 25: 37-42. PMID 30031282 DOI: 10.1016/J.Msard.2018.07.009 |
0.453 |
|
| 2018 |
Zivadinov R, Tavazzi E, Bergsland N, Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy D, Durfee J, Weinstock-Guttman B, Schweser F. Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis. Radiology. 180136. PMID 30015589 DOI: 10.1148/Radiol.2018180136 |
0.756 |
|
| 2018 |
Lin F, Zivadinov R, Hagemeier J, Weinstock-Guttman B, Vaughn C, Gandhi S, Jakimovski D, Hulst HE, Benedict RH, Bergsland N, Fuchs T, Dwyer MG. Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518788218. PMID 30004291 DOI: 10.1177/1352458518788218 |
0.627 |
|
| 2018 |
Fuchs TA, Carolus K, Benedict RHB, Bergsland N, Ramasamy D, Jakimovski D, Weinstock-Guttman B, Kuceyeski A, Zivadinov R, Dwyer MG. Impact of Focal White Matter Damage on Localized Subcortical Gray Matter Atrophy in Multiple Sclerosis: A 5-Year Study. Ajnr. American Journal of Neuroradiology. PMID 29976833 DOI: 10.3174/Ajnr.A5720 |
0.375 |
|
| 2018 |
Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Benedict RHB, Zivadinov R. Thalamic white matter in multiple sclerosis: A combined diffusion-tensor imaging and quantitative susceptibility mapping study. Human Brain Mapping. PMID 29923266 DOI: 10.1002/Hbm.24227 |
0.748 |
|
| 2018 |
Hagemeier J, Zivadinov R, Dwyer MG, Polak P, Bergsland N, Weinstock-Guttman B, Zalis J, Deistung A, Reichenbach JR, Schweser F. Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain. Neuroimage. Clinical. 18: 1007-1016. PMID 29868452 DOI: 10.1016/J.Nicl.2017.04.008 |
0.747 |
|
| 2018 |
Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock‐Guttman B, Zivadinov R. Atrophied Brain Lesion Volume: A New Imaging Biomarker in Multiple Sclerosis. Journal of Neuroimaging. 28: 490-495. PMID 29856910 DOI: 10.1111/Jon.12527 |
0.441 |
|
| 2018 |
Zivadinov R. Why Is Cognitive Impairment Present in Multiple Sclerosis? Insights from Functional MRI Radiology. 288: 552-553. PMID 29786484 DOI: 10.1148/Radiol.2018180719 |
0.405 |
|
| 2018 |
Zivadinov R, Tavazzi E, Hagemeier J, Carl E, Hojnacki D, Kolb C, Weinstock-Guttman B. The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study. Cns Drugs. 32: 763-770. PMID 29767815 DOI: 10.1007/S40263-018-0521-9 |
0.449 |
|
| 2018 |
Ziliotto N, Bernardi F, Jakimovski D, Baroni M, Marchetti G, Bergsland N, Ramasamy DP, Weinstock-Guttman B, Schweser F, Zamboni P, Ramanathan M, Zivadinov R. Hemostasis Biomarkers in Multiple Sclerosis. European Journal of Neurology. PMID 29758118 DOI: 10.1111/Ene.13681 |
0.457 |
|
| 2018 |
Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29749661 DOI: 10.1111/Jon.12518 |
0.513 |
|
| 2018 |
Fuchs TA, Dwyer MG, Kuceyeski A, Choudhery S, Carolus K, Li X, Mallory M, Weinstock-Guttman B, Jakimovski D, Ramasamy D, Zivadinov R, Benedict RHB. White matter tract network disruption explains reduced conscientiousness in multiple sclerosis. Human Brain Mapping. PMID 29740964 DOI: 10.1002/Hbm.24203 |
0.422 |
|
| 2018 |
Zivadinov R, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Kolodny S, Silva D, Medin J, Weinstock-Guttman B. No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study. Current Medical Research and Opinion. 1-10. PMID 29648900 DOI: 10.1080/03007995.2018.1458708 |
0.457 |
|
| 2018 |
Zivadinov R, Bergsland N, Hagemeier J, Carl E, Kolb H, Hojnacki D, Weinstock-Guttman B. Effect of teriflunomide on gray and white matter brain pathology in multiple sclerosis using volumetric and diffusion-tensor imaging MRI measures. Journal of the Neurological Sciences. 388: 175-181. PMID 29627017 DOI: 10.1016/J.Jns.2018.03.028 |
0.45 |
|
| 2018 |
Roy S, Drake A, Snyder S, Cline B, Khan A, Fuchs T, Zivadinov R, Weinstock-Guttman B, Szigeti K, Benedict RHB. Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease. Multiple Sclerosis and Related Disorders. 22: 52-56. PMID 29574353 DOI: 10.1016/J.Msard.2018.03.008 |
0.458 |
|
| 2018 |
Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study Journal of the Neurological Sciences. 387: 152-156. PMID 29571854 DOI: 10.1016/J.Jns.2018.02.023 |
0.338 |
|
| 2018 |
Dwyer MG, Hagemeier J, Bergsland N, Horakova D, Korn JR, Khan N, Uher T, Medin J, Silva D, Vaneckova M, Havrdova EK, Zivadinov R. Establishing pathological cut-offs for lateral ventricular volume expansion rates. Neuroimage. Clinical. 18: 494-501. PMID 29527505 DOI: 10.1016/J.Nicl.2018.02.009 |
0.396 |
|
| 2018 |
Kim S, Chang L, Weinstock-Guttman B, Gandhi S, Jakimovski D, Carl E, Zivadinov R, Ramanathan M. Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study. Journal of Alternative and Complementary Medicine (New York, N.Y.). PMID 29498537 DOI: 10.1089/Acm.2017.0268 |
0.46 |
|
| 2018 |
Uher T, Krasensky J, Sobisek L, Seidl Z, Bergsland N, Dwyer MG, Havrdova EK, Zivadinov R, Horakova D, Vaneckova M. The Role of High‐Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis Journal of Neuroimaging. 28: 328-337. PMID 29485230 DOI: 10.1111/Jon.12505 |
0.437 |
|
| 2018 |
Zivadinov R, Ramasamy DP, Hagemeier J, Kolb C, Bergsland N, Schweser F, Dwyer MG, Weinstock-Guttman B, Hojnacki D. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis. American Journal of Neuroradiology. 39: 642-647. PMID 29439125 DOI: 10.3174/Ajnr.A5541 |
0.394 |
|
| 2018 |
Guttuso T, Bergsland N, Hagemeier J, Lichter DG, Pasternak O, Zivadinov R. Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease American Journal of Neuroradiology. 39: 479-484. PMID 29419398 DOI: 10.3174/Ajnr.A5545 |
0.323 |
|
| 2018 |
Roy S, Drake A, Fuchs T, Dwyer MG, Zivadinov R, Chapman BP, Weinstock-Guttman B, Benedict RH. Longitudinal personality change associated with cognitive decline in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517753720. PMID 29363385 DOI: 10.1177/1352458517753720 |
0.602 |
|
| 2018 |
Schweser F, Preda M, Zivadinov R. Susceptibility Weighted MRI in Rodents at 9.4 T. Methods of Molecular Biology. 1718: 205-234. PMID 29341011 DOI: 10.1007/978-1-4939-7531-0_13 |
0.654 |
|
| 2018 |
Zivadinov R, Hagemeier J, Bergsland N, Tavazzi E, Weinstock‐Guttman B. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study. European Journal of Neurology. 25: 584. PMID 29316038 DOI: 10.1111/Ene.13562 |
0.44 |
|
| 2018 |
Jakimovski D, Kolb C, Ramanathan M, Zivadinov R, Weinstock-Guttman B. Interferon β for Multiple Sclerosis. Cold Spring Harbor Perspectives in Medicine. PMID 29311124 DOI: 10.1101/Cshperspect.A032003 |
0.386 |
|
| 2018 |
Zivadinov R, Weinstock-Guttman B. Multiple sclerosis: Extracranial venous angioplasty is ineffective to treat MS. Nature Reviews Neurology. 14: 129-130. PMID 29302063 DOI: 10.1038/Nrneurol.2017.180 |
0.455 |
|
| 2018 |
Belov P, Jakimovski D, Krawiecki J, Magnano C, Hagemeier J, Pelizzari L, Weinstock-Guttman B, Zivadinov R. Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis. American Journal of Neuroradiology. 39: 123-130. PMID 29217748 DOI: 10.3174/Ajnr.A5469 |
0.8 |
|
| 2018 |
Hagemeier J, Ramanathan M, Schweser F, Dwyer MG, Lin F, Bergsland N, Weinstock-Guttman B, Zivadinov R. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. Neuroimage. Clinical. 17: 530-540. PMID 29201641 DOI: 10.1016/J.Nicl.2017.11.003 |
0.723 |
|
| 2018 |
Bergsland N, Horakova D, Dwyer MG, Uher T, Vaneckova M, Tyblova M, Seidl Z, Krasensky J, Havrdova E, Zivadinov R. Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study. Neuroimage. Clinical. 17: 444-451. PMID 29159057 DOI: 10.1016/J.Nicl.2017.11.002 |
0.473 |
|
| 2018 |
Beadnall HN, Ly L, Wang C, Billiet T, Ribbens A, Hecke WV, Zivadinov R, Barnett MH. 103 Exploring the influence of quantitative magnetic resonance imaging on decision-making in multiple sclerosis clinical practice Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Anzan.102 |
0.45 |
|
| 2018 |
Haussig S, Mangner N, Dwyer M, Lehmkuhl L, Luecke C, Woitek F, Holzhey D, Zivadinov R, Linke A. TCT-356 Correlation of neuromarkers and brain injury after TAVR – results from CLEAN-TAVI trial Journal of the American College of Cardiology. 72. DOI: 10.1016/J.Jacc.2018.08.1506 |
0.343 |
|
| 2017 |
Weinstock-Guttman B, Medin J, Khan N, Korn JR, Lathi E, Silversteen J, Calkwood J, Silva D, Zivadinov R. Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study. Cns Drugs. PMID 29270772 DOI: 10.1007/S40263-017-0482-4 |
0.455 |
|
| 2017 |
Younus Z, Vaughn CB, Sanai SA, Kavak KS, Gupta S, Nadeem M, Teter BE, Noyes K, Zivadinov R, Edwards K, Coyle PK, Goodman A, Weinstock-Guttman B. Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple Sclerosis. International Journal of Ms Care. 19: 297-302. PMID 29270087 DOI: 10.7224/1537-2073.2016-058 |
0.39 |
|
| 2017 |
Zivadinov R, Bergsland N, Korn JR, Dwyer MG, Khan N, Medin J, Price JC, Weinstock-Guttman B, Silva D. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS. Ajnr. American Journal of Neuroradiology. PMID 29170269 DOI: 10.3174/Ajnr.A5442 |
0.482 |
|
| 2017 |
Uher T, Vaneckova M, Krasensky J, Sobisek L, Tyblova M, Volna J, Seidl Z, Bergsland N, Dwyer MG, Zivadinov R, De Stefano N, Sormani MP, Havrdova EK, Horakova D. Pathological cut-offs of global and regional brain volume loss in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517742739. PMID 29143562 DOI: 10.1177/1352458517742739 |
0.421 |
|
| 2017 |
Schweser F, Raffaini Duarte Martins AL, Hagemeier J, Lin F, Hanspach J, Weinstock-Guttman B, Hametner S, Bergsland NP, Dwyer MG, Zivadinov R. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality. Neuroimage. PMID 29097315 DOI: 10.1016/J.Neuroimage.2017.10.063 |
0.757 |
|
| 2017 |
Modica CM, Schweser F, Sudyn ML, Bertolino N, Preda M, Polak P, Siebert DM, Krawiecki JC, Sveinsson M, Hagemeier J, Dwyer MG, Pol S, Zivadinov R. Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis. Plos One. 12: e0182729. PMID 28796815 DOI: 10.1371/Journal.Pone.0182729 |
0.769 |
|
| 2017 |
Caprio MG, Marr K, Gandhi S, Jakimovski D, Hagemeier J, Weinstock-Guttman B, Zivadinov R, Mancini M. Centralized and local color Doppler ultrasound reading agreement for diagnosis of the chronic cerebrospinal venous insufficiency in patients with Multiple Sclerosis. Current Neurovascular Research. PMID 28721810 DOI: 10.2174/1567202614666170718095203 |
0.399 |
|
| 2017 |
Dwyer MG, Silva D, Bergsland N, Horakova D, Ramasamy D, Durfee J, Vaneckova M, Havrdova E, Zivadinov R. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis. Neuroimage. Clinical. 15: 769-779. PMID 28706852 DOI: 10.1016/J.Nicl.2017.06.022 |
0.448 |
|
| 2017 |
Jakimovski D, Weinstock-Guttman B, Ramanathan M, Kolb C, Hojnacki D, Minagar A, Zivadinov R. Ocrelizumab: A B-cell Depleting Therapy for Multiple Sclerosis. Expert Opinion On Biological Therapy. PMID 28658986 DOI: 10.1080/14712598.2017.1347632 |
0.446 |
|
| 2017 |
Woodward MR, Dwyer MG, Bergsland N, Hagemeier J, Zivadinov R, Benedict RH, Szigeti K. Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease. Psychiatry Research. 266: 90-95. PMID 28644998 DOI: 10.1016/J.Pscychresns.2017.06.004 |
0.541 |
|
| 2017 |
Uher T, Krasensky J, Vaneckova M, Sobisek L, Seidl Z, Havrdova E, Bergsland N, Dwyer MG, Horakova D, Zivadinov R. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 28464417 DOI: 10.1111/Jon.12445 |
0.446 |
|
| 2017 |
Roy S, Drake AS, Eizaguirre MB, Zivadinov R, Weinstock-Guttman B, Chapman BP, Benedict RH. Trait neuroticism, extraversion, and conscientiousness in multiple sclerosis: Link to cognitive impairment? Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517695467. PMID 28273781 DOI: 10.1177/1352458517695467 |
0.655 |
|
| 2017 |
Hanspach J, Dwyer MG, Bergsland NP, Feng X, Hagemeier J, Bertolino N, Polak P, Reichenbach JR, Zivadinov R, Schweser F. Methods for the computation of templates from quantitative magnetic susceptibility maps (QSM): Toward improved atlas- and voxel-based analyses (VBA). Journal of Magnetic Resonance Imaging : Jmri. PMID 28263417 DOI: 10.1002/Jmri.25671 |
0.637 |
|
| 2017 |
Feng X, Deistung A, Dwyer MG, Hagemeier J, Polak P, Lebenberg J, Frouin F, Zivadinov R, Reichenbach JR, Schweser F. An improved FSL-FIRST pipeline for subcortical gray matter segmentation to study abnormal brain anatomy using quantitative susceptibility mapping (QSM). Magnetic Resonance Imaging. PMID 28188873 DOI: 10.1016/J.Mri.2017.02.002 |
0.675 |
|
| 2017 |
Uher T, Havrdova E, Sobisek L, Krasensky J, Vaneckova M, Seidl Z, Tyblova M, Ramasamy D, Zivadinov R, Horakova D. Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?: Multiple Sclerosis Journal. 23: 242-252. PMID 27230790 DOI: 10.1177/1352458516650525 |
0.469 |
|
| 2017 |
Uher T, Vaneckova M, Sobisek L, Tyblova M, Seidl Z, Krasensky J, Ramasamy D, Zivadinov R, Havrdova E, Kalincik T, Horakova D. Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis: Multiple Sclerosis Journal. 23: 51-61. PMID 27053635 DOI: 10.1177/1352458516642314 |
0.413 |
|
| 2017 |
Belov P, Magnano C, Krawiecki J, Hagemeier J, Bergsland N, Beggs C, Zivadinov R. Age-related brain atrophy may be mitigated by internal jugular vein enlargement in male individuals without neurologic disease. Phlebology. 32: 125-134. PMID 26911619 DOI: 10.1177/0268355516633610 |
0.793 |
|
| 2017 |
Jakimovski D, Marr K, Mancini M, Caprio MG, Gandhi S, Bergsland N, Paunkoski I, Hagemeier J, Chandra A, Weinstock-Guttman B, Zivadinov R. Global and regional brain atrophy is associated with low or retrograde facial vein flow in multiple sclerosis Veins and Lymphatics. 6. DOI: 10.4081/Vl.2017.6976 |
0.501 |
|
| 2017 |
Dwyer M, Linke A, Kraemer C, White R, Lazar R, Kapadia S, Kodali S, Engels T, Parhizgar A, Mehran R, Makkar R, Anwaruddin S, Leon M, Zivadinov R. TCT-422 Pre-procedural white matter lesion burden predicts MRI outcomes in transcatheter aortic valve replacement (TAVR): The Sentinel Trial Journal of the American College of Cardiology. 70. DOI: 10.1016/J.Jacc.2017.09.525 |
0.304 |
|
| 2016 |
Uher T, Fellows K, Horakova D, Zivadinov R, Vaneckova M, Sobisek L, Tyblova M, Seidl Z, Krasensky J, Bergsland N, Weinstock-Guttman B, Havrdova E, Ramanathan M. Serum Lipid Profile Changes Predict Neurodegeneration in Interferon-B1a Treated Multiple Sclerosis Patients. Journal of Lipid Research. PMID 27923871 DOI: 10.1194/Jlr.M072751 |
0.42 |
|
| 2016 |
Zivadinov R, Khan N, Medin J, Christoffersen P, Price J, Korn JR, Bonzani I, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 27918139 DOI: 10.1111/Jon.12411 |
0.485 |
|
| 2016 |
Roy S, Frndak S, Drake AS, Irwin L, Zivadinov R, Weinstock-Guttman B, Benedict RH. Differential effects of aging on motor and cognitive functioning in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27885064 DOI: 10.1177/1352458516679036 |
0.608 |
|
| 2016 |
Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, ... ... Zivadinov R, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nature Reviews. Neurology. PMID 27834394 DOI: 10.1038/Nrneurol.2016.166 |
0.481 |
|
| 2016 |
Zivadinov R, Ramasamy DP, Vaneckova M, Gandhi S, Chandra A, Hagemeier J, Bergsland N, Polak P, Benedict RH, Hojnacki D, Weinstock-Guttman B. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27811339 DOI: 10.1177/1352458516678083 |
0.658 |
|
| 2016 |
Mokin M, Zivadinov R, Dwyer MG, Lazar RM, Hopkins LN, Siddiqui AH. Transcatheter aortic valve replacement: perioperative stroke and beyond. Expert Review of Neurotherapeutics. PMID 27786568 DOI: 10.1080/14737175.2017.1253475 |
0.311 |
|
| 2016 |
Mukhopadhyay S, Fellows K, Browne RW, Khare P, Krishnan Radhakrishnan S, Hagemeier J, Weinstock-Guttman B, Zivadinov R, Ramanathan M. Interdependence of oxysterols with cholesterol profiles in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27589058 DOI: 10.1177/1352458516666187 |
0.44 |
|
| 2016 |
Banwell B, Arnold DL, Tillema JM, Rocca MA, Filippi M, Weinstock-Guttman B, Zivadinov R, Sormani MP. MRI in the evaluation of pediatric multiple sclerosis. Neurology. 87: S88-96. PMID 27572868 DOI: 10.1212/Wnl.0000000000002787 |
0.51 |
|
| 2016 |
Hagemeier J, Woodward MR, Rafique UA, Amrutkar CV, Bergsland N, Dwyer MG, Benedict R, Zivadinov R, Szigeti K. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy. Psychiatry Research. 255: 87-93. PMID 27567325 DOI: 10.1016/J.Pscychresns.2016.08.003 |
0.565 |
|
| 2016 |
Haussig S, Mangner N, Dwyer MG, Lehmkuhl L, Lücke C, Woitek F, Holzhey DM, Mohr FW, Gutberlet M, Zivadinov R, Schuler G, Linke A. Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial Jama. 316: 592-601. PMID 27532914 DOI: 10.1001/Jama.2016.10302 |
0.33 |
|
| 2016 |
Khan O, Rieckmann P, Boyko A, Selmaj K, Ashtamker N, Davis MD, Kolodny S, Zivadinov R. Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 27503905 DOI: 10.1177/1352458516664033 |
0.359 |
|
| 2016 |
Schwartz CE, Dwyer MG, Benedict R, Weinstock-Guttman B, Bergsland NP, Li J, Ramanathan M, Zivadinov R. Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study. Bmc Neurology. 16: 108. PMID 27430316 DOI: 10.1186/S12883-016-0624-1 |
0.641 |
|
| 2016 |
Zivadinov R, Cookfair DL, Krupp L, Miller AE, Lava N, Coyle PK, Goodman AD, Jubelt B, Lenihan M, Herbert J, Gottesman M, Snyder DH, Apatoff BR, Teter BE, Perel AB, et al. Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC). Bmc Neurology. 16: 102. PMID 27416843 DOI: 10.1186/S12883-016-0623-2 |
0.442 |
|
| 2016 |
Gandhi S, Jakimovski D, Ahmed R, Hojnacki D, Kolb C, Weinstock-Guttman B, Zivadinov R. Use of Natalizumab in Multiple Sclerosis: Current Perspectives. Expert Opinion On Biological Therapy. PMID 27413840 DOI: 10.1080/14712598.2016.1213810 |
0.374 |
|
| 2016 |
Zivadinov R, Dwyer MG, Bergsland N. Brain atrophy measurements should be used to guide therapy monitoring in MS – YES Multiple Sclerosis Journal. 22: 1522-1524. PMID 27335098 DOI: 10.1177/1352458516649253 |
0.414 |
|
| 2016 |
Zivadinov R, Ramasamy DP, Benedict RR, Polak P, Hagemeier J, Magnano C, Dwyer MG, Bergsland N, Bertolino N, Weinstock-Guttman B, Kolb C, Hojnacki D, Utriainen D, Haacke EM, Schweser F. Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study. Radiology. 160060. PMID 27308776 DOI: 10.1148/Radiol.2016160060 |
0.767 |
|
| 2016 |
Bergsland N, Tavazzi E, Laganà MM, Baglio F, Cecconi P, Viotti S, Zivadinov R, Baselli G, Rovaris M. White Matter Tract Injury is Associated with Deep Gray Matter Iron Deposition in Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 27239049 DOI: 10.1111/Jon.12364 |
0.444 |
|
| 2016 |
Roy S, Schwartz CE, Duberstein P, Dwyer MG, Zivadinov R, Bergsland N, Powell V, Weinstock-Guttman B, Benedict RH. Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis. Journal of the International Neuropsychological Society : Jins. 1-8. PMID 27151620 DOI: 10.1017/S1355617716000333 |
0.561 |
|
| 2016 |
Beggs CB, Magnano C, Belov P, Krawiecki J, Ramasamy DP, Hagemeier J, Zivadinov R. Internal Jugular Vein Cross-Sectional Area and Cerebrospinal Fluid Pulsatility in the Aqueduct of Sylvius: A Comparative Study between Healthy Subjects and Multiple Sclerosis Patients. Plos One. 11: e0153960. PMID 27135831 DOI: 10.1371/Journal.Pone.0153960 |
0.809 |
|
| 2016 |
Zivadinov R, Jakimovski D, Gandhi S, Ahmed R, Dwyer MG, Horakova D, Weinstock-Guttman B, Benedict RR, Vaneckova M, Barnett M, Bergsland N. Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine. Expert Review of Neurotherapeutics. PMID 27105209 DOI: 10.1080/14737175.2016.1181543 |
0.499 |
|
| 2016 |
Greenberg SJ, Zivadinov R, Lee-Kwen P, Sharma J, Planter M, Umhauer M, Glenister N, Bakshi R. Fludarabine add-on therapy in interferon-beta-treated patients with multiple sclerosis experiencing breakthrough disease. Therapeutic Advances in Neurological Disorders. 9: 105-17. PMID 27006698 DOI: 10.1177/1756285615626049 |
0.34 |
|
| 2016 |
Beatty C, Bowler RA, Farooq O, Dudeck L, Ramasamy D, Yeh EA, Zivadinov R, Weinstock-Guttman B, Parrish JB. Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis. Pediatric Neurology. 57: 64-73. PMID 26996404 DOI: 10.1016/J.Pediatrneurol.2016.01.003 |
0.333 |
|
| 2016 |
Sanai SA, Saini V, Benedict RH, Zivadinov R, Teter BE, Ramanathan M, Weinstock-Guttman B. Aging and multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26895718 DOI: 10.1177/1352458516634871 |
0.621 |
|
| 2016 |
Magnano C, Belov P, Krawiecki J, Hagemeier J, Beggs C, Zivadinov R. Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals Plos One. 11. PMID 26895434 DOI: 10.1371/Journal.Pone.0149532 |
0.766 |
|
| 2016 |
Zivadinov R, Raj B, Ramanathan M, Teter B, Durfee J, Dwyer MG, Bergsland N, Kolb C, Hojnacki D, Benedict RH, Weinstock-Guttman B. Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis. Ajnr. American Journal of Neuroradiology. PMID 26892983 DOI: 10.3174/Ajnr.A4681 |
0.646 |
|
| 2016 |
Zivadinov R, Uher T, Hagemeier J, Vaneckova M, Ramasamy DP, Tyblova M, Bergsland N, Seidl Z, Dwyer MG, Krasensky J, Havrdova E, Horakova D. A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients. Multiple Sclerosis Journal. 22: 1709-1718. PMID 26883943 DOI: 10.1177/1352458516629769 |
0.42 |
|
| 2016 |
Motl RW, Zivadinov R, Bergsland N, Benedict RH. Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study. Neurodegenerative Disease Management. 6: 23-9. PMID 26782314 DOI: 10.2217/Nmt.15.71 |
0.628 |
|
| 2016 |
Zivadinov R, Cerza N, Hagemeier J, Carl E, Badgett D, Ramasamy DP, Weinstock-Guttman B, Ramanathan M. Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS. Neurology® Neuroimmunology & Neuroinflammation. 3: e190. PMID 26770996 DOI: 10.1212/Nxi.0000000000000190 |
0.457 |
|
| 2016 |
Uher T, Horakova D, Tyblova M, Zeman D, Krasulova E, Mrazova K, Seidl Z, Vaneckova M, Krasensky J, Weinstock-Guttman B, Ramanathan M, Havrdova E, Zivadinov R. Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later. Multiple Sclerosis (Houndmills, Basingstoke, England). 22: 770-81. PMID 26362893 DOI: 10.1177/1352458515601903 |
0.483 |
|
| 2016 |
Modica CM, Sudyn ML, Zivadinov R, Pawlowski DR. Shedding Risk with Intracerebral Inoculation of Theiler’s Murine Encephalomyelitis Virus: Informing a Risk Assessment Applied Biosafety. 21: 142-150. DOI: 10.1177/1535676016661770 |
0.765 |
|
| 2016 |
Zivadinov R, Hojnacki D, Bergsland N, Kennedy C, Hagemeier J, Melia R, Ramasamy DP, Durfee J, Carl E, Dwyer MG, Weinstock-Guttman B. Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years European Journal of Neurology. 23: 1101-1109. DOI: 10.1111/Ene.12992 |
0.498 |
|
| 2016 |
Khan N, Weinstock-Guttman B, Medin J, Christoffersen P, Price J, Bonzani I, Zivadinov R. Development Of An Innovative Observational Study To Assess Multiple Sclerosis Disease Progression In Real World Clinical Practice Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1679 |
0.363 |
|
| 2015 |
Dwyer MG, Zivadinov R, Tao Y, Zhang X, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Weinstock-Guttman B, Hayward B, Dangond F, Markovic-Plese S. Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial. Bmc Neurology. 15: 232. PMID 26559139 DOI: 10.1186/S12883-015-0488-9 |
0.367 |
|
| 2015 |
Bergsland N, Zivadinov R, Dwyer MG, Weinstock-Guttman B, Benedict RH. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26541795 DOI: 10.1177/1352458515616204 |
0.653 |
|
| 2015 |
Graziano E, Hagemeier J, Weinstock-Guttman B, Ramasamy DP, Zivadinov R. Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients. Neuroimage: Clinical. 9: 110-116. PMID 26448911 DOI: 10.1016/J.Nicl.2015.07.013 |
0.489 |
|
| 2015 |
Zivadinov R, Dwyer MG, Ramasamy DP, Davis MD, Steinerman JR, Khan O. The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 26394270 DOI: 10.1111/Jon.12293 |
0.363 |
|
| 2015 |
Schwartz CE, Ayandeh A, Ramanathan M, Benedict R, Dwyer MG, Weinstock-Guttman B, Zivadinov R. Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study. Bmc Neurology. 15: 135. PMID 26264858 DOI: 10.1186/S12883-015-0395-0 |
0.63 |
|
| 2015 |
Roy S, Rodgers J, Drake AS, Zivadinov R, Weinstock-Guttman B, Benedict RH. Stable neuropsychiatric status in multiple sclerosis: a 3-year study. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26227003 DOI: 10.1177/1352458515597570 |
0.629 |
|
| 2015 |
Varosanec M, Uher T, Horakova D, Hagemeier J, Bergsland N, Tyblova M, Seidl Z, Vaneckova M, Krasensky J, Dwyer MG, Havrdova E, Zivadinov R. Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated Syndrome American Journal of Neuroradiology. 36: 1457-1464. PMID 26113068 DOI: 10.3174/Ajnr.A4330 |
0.406 |
|
| 2015 |
Alexander JS, Chervenak R, Weinstock-Guttman B, Tsunoda I, Ramanathan M, Martinez N, Omura S, Sato F, Chaitanya GV, Minagar A, McGee J, Jennings MH, Monceaux C, Becker F, Cvek U, ... ... Zivadinov R, et al. Blood circulating microparticle species in relapsing-remitting and secondary progressive multiple sclerosis. A case-control, cross sectional study with conventional MRI and advanced iron content imaging outcomes. Journal of the Neurological Sciences. 355: 84-9. PMID 26073484 DOI: 10.1016/J.Jns.2015.05.027 |
0.474 |
|
| 2015 |
Cesar B, Dwyer MG, Shucard JL, Polak P, Bergsland N, Benedict RH, Weinstock-Guttman B, Shucard DW, Zivadinov R. Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus. Ajnr. American Journal of Neuroradiology. PMID 26066628 DOI: 10.3174/Ajnr.A4354 |
0.633 |
|
| 2015 |
Malyavantham K, Weinstock-Guttman B, Suresh L, Zivadinov R, Shanahan T, Badgett D, Ramanathan M. Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis. Plos One. 10: e0129503. PMID 26065913 DOI: 10.1371/Journal.Pone.0129503 |
0.44 |
|
| 2015 |
Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F, Weinstock-Guttman B. A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders. 8: 59-70. PMID 25941537 DOI: 10.1177/1756285615572953 |
0.417 |
|
| 2015 |
Modica CM, Bergsland N, Dwyer MG, Ramasamy DP, Carl E, Zivadinov R, Benedict RH. Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25921038 DOI: 10.1177/1352458515579443 |
0.816 |
|
| 2015 |
Uher T, Horakova D, Kalincik T, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 1113-23. PMID 25904020 DOI: 10.1111/Ene.12716 |
0.355 |
|
| 2015 |
Beggs CB, Magnano C, Shepherd SJ, Belov P, Ramasamy DP, Hagemeier J, Zivadinov R. Dirty-Appearing White Matter in the Brain is Associated with Altered Cerebrospinal Fluid Pulsatility and Hypertension in Individuals without Neurologic Disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 25893376 DOI: 10.1111/Jon.12249 |
0.35 |
|
| 2015 |
Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F. Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly. Journal of Neuroimmunology. 281: 44-50. PMID 25867467 DOI: 10.1016/J.Jneuroim.2015.03.002 |
0.366 |
|
| 2015 |
Mak E, Dwyer MG, Ramasamy DP, Au WL, Tan LC, Zivadinov R, Kandiah N. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 25753576 DOI: 10.1111/Jon.12230 |
0.303 |
|
| 2015 |
Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E, Ramasamy DP, Cherneva M, Durfee J, Bergsland N, Dwyer MG, Kolb C, Hojnacki D, Ramanathan M, Zivadinov R. Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 25722366 DOI: 10.1136/Jnnp-2014-310051 |
0.443 |
|
| 2015 |
Hagemeier J, Tong O, Dwyer MG, Schweser F, Ramanathan M, Zivadinov R. Effects of diet on brain iron levels among healthy individuals: an MRI pilot study. Neurobiology of Aging. 36: 1678-85. PMID 25680267 DOI: 10.1016/J.Neurobiolaging.2015.01.010 |
0.665 |
|
| 2015 |
Zivadinov R, Dwyer M, Barkay H, Steinerman JR, Knappertz V, Khan O. Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis Journal of Neurology. 262: 648-653. PMID 25542295 DOI: 10.1007/S00415-014-7616-0 |
0.322 |
|
| 2015 |
Modica CM, Zivadinov R, Dwyer MG, Bergsland N, Weeks AR, Benedict RH. Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 36: 57-62. PMID 24948507 DOI: 10.3174/Ajnr.A3998 |
0.823 |
|
| 2015 |
Eraksoy M, Butzkueven H, Ziemssen T, Zivadinov R. Time for change - Evolution of real-world evidence outcome measures in multiple sclerosis exemplified by fingolimod European Neurological Review. 9: 136-142. DOI: 10.17925/Enr.2014.09.02.136 |
0.326 |
|
| 2015 |
Schwartz CE, Ayandeh A, Ramanathan M, Benedict R, Dwyer MG, Weinstock-Guttman B, Zivadinov R. Reserve-building activities in multiple sclerosis patients and healthy controls: A descriptive study Bmc Neurology. 15. DOI: 10.1186/s12883-015-0395-0 |
0.535 |
|
| 2014 |
Uher T, Benedict RH, Horakova D, Bergsland N, Dusankova JB, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment. Journal of the Neurological Sciences. 347: 229-34. PMID 25456460 DOI: 10.1016/J.Jns.2014.10.002 |
0.537 |
|
| 2014 |
Uher T, Horakova D, Bergsland N, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. MRI correlates of disability progression in patients with CIS over 48 months Neuroimage: Clinical. 6: 312-319. PMID 25379444 DOI: 10.1016/J.Nicl.2014.09.015 |
0.49 |
|
| 2014 |
Mak E, Bergsland N, Dwyer MG, Zivadinov R, Kandiah N. Subcortical Atrophy Is Associated with Cognitive Impairment in Mild Parkinson Disease: A Combined Investigation of Volumetric Changes, Cortical Thickness, and Vertex-Based Shape Analysis American Journal of Neuroradiology. 35: 2257-2264. PMID 25082821 DOI: 10.3174/Ajnr.A4055 |
0.375 |
|
| 2014 |
Siddiqui AH, Zivadinov R, Benedict RH, Karmon Y, Yu J, Hartney ML, Marr KL, Valnarov V, Kennedy CL, Ramanathan M, Ramasamy DP, Dolic K, Hojnacki DW, Carl E, Levy EI, et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology. 83: 441-9. PMID 24975855 DOI: 10.1212/Wnl.0000000000000638 |
0.622 |
|
| 2014 |
Uher T, Blahova-Dusankova J, Horakova D, Bergsland N, Tyblova M, Benedict RH, Kalincik T, Ramasamy DP, Seidl Z, Hagermeier J, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome. Journal of Neurology. 261: 1735-44. PMID 24952618 DOI: 10.1007/S00415-014-7413-9 |
0.592 |
|
| 2014 |
Browne RW, Weinstock-Guttman B, Zivadinov R, Horakova D, Bodziak ML, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Qu J, et al. Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: Results from a multi-center study. The Journal of Steroid Biochemistry and Molecular Biology. 143: 424-33. PMID 24950029 DOI: 10.1016/J.Jsbmb.2014.06.007 |
0.392 |
|
| 2014 |
Goldberg H, Weinstock A, Bergsland N, Dwyer MG, Farooq O, Sazgar M, Poloni G, Treu C, Weinstock-Guttman B, Ramanathan M, Zivadinov R. MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy. Bmc Neurology. 14: 131. PMID 24938118 DOI: 10.1186/1471-2377-14-131 |
0.327 |
|
| 2014 |
Zivadinov R, Chin J, Horakova D, Bergsland N, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Hagemeier J, Tyblova M, Carl E, Krasensky J, Vaneckova M, Seidl Z, Dwyer MG, Havrdova E, et al. Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: results from the multi-center set study. Journal of Neuroimmunology. 273: 58-64. PMID 24907902 DOI: 10.1016/J.Jneuroim.2014.04.012 |
0.311 |
|
| 2014 |
Hagemeier J, Heininen-Brown M, Gabelic T, Guttuso T, Silvestri N, Lichter D, Fugoso LE, Bergsland N, Carl E, Geurts JJ, Weinstock-Guttman B, Zivadinov R. Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. Ajnr. American Journal of Neuroradiology. 35: 1916-23. PMID 24874536 DOI: 10.3174/Ajnr.A3969 |
0.34 |
|
| 2014 |
Benedict RH, Morrow S, Rodgers J, Hojnacki D, Bucello MA, Zivadinov R, Weinstock-Guttman B. Characterizing cognitive function during relapse in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1745-52. PMID 24842959 DOI: 10.1177/1352458514533229 |
0.641 |
|
| 2014 |
Zivadinov R, Bergsland N, Cappellani R, Hagemeier J, Melia R, Carl E, Dwyer MG, Lincoff N, Weinstock-Guttman B, Ramanathan M. Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients. European Journal of Neurology. 21: 1137-e61. PMID 24779967 DOI: 10.1111/Ene.12449 |
0.404 |
|
| 2014 |
Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B. Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study. Plos One. 9: e91098. PMID 24625687 DOI: 10.1371/Journal.Pone.0091098 |
0.376 |
|
| 2014 |
Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E, Zivadinov R. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1109-1115. PMID 24554101 DOI: 10.1136/Jnnp-2013-306906 |
0.477 |
|
| 2014 |
Browne RW, Weinstock-Guttman B, Horakova D, Zivadinov R, Bodziak ML, Tamaño-Blanco M, Badgett D, Tyblova M, Vaneckova M, Seidl Z, Krasensky J, Bergsland N, Ramasamy DP, Hagemeier J, Havrdova E, et al. Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 859-64. PMID 24470599 DOI: 10.1136/Jnnp-2013-307106 |
0.3 |
|
| 2014 |
Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R. Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome Journal of the Neurological Sciences. 338: 128-134. PMID 24423584 DOI: 10.1016/J.Jns.2013.12.031 |
0.394 |
|
| 2014 |
Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R. Subcortical Deep Gray Matter Pathology in Patients with Multiple Sclerosis Is Associated with White Matter Lesion Burden and Atrophy but Not with Cortical Atrophy: A Diffusion Tensor MRI Study American Journal of Neuroradiology. 35: 912-919. PMID 24335548 DOI: 10.3174/Ajnr.A3788 |
0.479 |
|
| 2014 |
Dwyer MG, Bergsland N, Zivadinov R. Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model. Neuroimage. 90: 207-217. PMID 24333394 DOI: 10.1016/J.Neuroimage.2013.12.004 |
0.336 |
|
| 2014 |
Gupta S, Zivadinov R, Ramasamy D, Ambrus JL. Reversible cerebral vasoconstriction syndrome (RCVS) in antiphospholipid antibody syndrome (APLA): the role of centrally acting vasodilators. Case series and review of literature. Clinical Rheumatology. 33: 1829-1833. PMID 24277114 DOI: 10.1007/S10067-013-2434-9 |
0.356 |
|
| 2014 |
Chung CP, Beggs C, Wang PN, Bergsland N, Shepherd S, Cheng CY, Ramasamy DP, Dwyer MG, Hu HH, Zivadinov R. Jugular venous reflux and white matter abnormalities in Alzheimer's disease: a pilot study. Journal of Alzheimer's Disease : Jad. 39: 601-9. PMID 24217278 DOI: 10.3233/Jad-131112 |
0.38 |
|
| 2014 |
Gabelic T, Ramasamy DP, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Hojnacki D, Ramanathan M, Zivadinov R. Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis. Ajnr. American Journal of Neuroradiology. 35: 106-12. PMID 23886745 DOI: 10.3174/Ajnr.A3653 |
0.424 |
|
| 2014 |
Barnett Y, Sutton IJ, Ghadiri M, Masters L, Zivadinov R, Barnett MH. Conventional and advanced imaging in neuromyelitis optica. Ajnr. American Journal of Neuroradiology. 35: 1458-66. PMID 23764723 DOI: 10.3174/Ajnr.A3592 |
0.419 |
|
| 2014 |
Donohue K, Cox JL, Dwyer MG, Aliotta R, Corwin M, Weinstock-Guttman B, Ann Yeh E, Zivadinov R. No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 24: 63-7. PMID 23317029 DOI: 10.1111/J.1552-6569.2012.00775.X |
0.431 |
|
| 2014 |
Aliotta R, Cox JL, Donohue K, Weinstock-Guttman B, Yeh EA, Polak P, Dwyer MG, Zivadinov R. Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis. Human Brain Mapping. 35: 53-60. PMID 22936429 DOI: 10.1002/Hbm.22148 |
0.448 |
|
| 2014 |
Magnano C, Belov P, Krawiecki J, Hagemeier J, Zivadinov R. Internal jugular vein narrowing and body mass index in healthy individuals and multiple sclerosis patients Veins and Lymphatics. 3. DOI: 10.4081/Vl.2014.4632 |
0.818 |
|
| 2013 |
Zivadinov R. Is there a link between the extracranial venous system and central nervous system pathology Bmc Medicine. 11: 259-259. PMID 24344725 DOI: 10.1186/1741-7015-11-259 |
0.334 |
|
| 2013 |
Gabelic T, Weinstock-Guttman B, Melia R, Lincoff N, Masud MW, Kennedy C, Brinar V, Ramasamy DP, Carl E, Bergsland N, Ramanathan M, Zivadinov R. Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients. Clinical Neurology and Neurosurgery. 115: S49-54. PMID 24321155 DOI: 10.1016/J.Clineuro.2013.09.021 |
0.395 |
|
| 2013 |
Dolezal O, Gabelic T, Horakova D, Bergsland N, Dwyer MG, Seidl Z, Krasensky J, Ramasamy DP, Vaneckova M, Havrdova E, Zivadinov R. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study. Clinical Neurology and Neurosurgery. 115. PMID 24321154 DOI: 10.1016/J.Clineuro.2013.09.020 |
0.427 |
|
| 2013 |
Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, ... ... Zivadinov R, et al. Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. Bmc Neurology. 13: 173. PMID 24225378 DOI: 10.1186/1471-2377-13-173 |
0.44 |
|
| 2013 |
Beggs C, Chung CP, Bergsland N, Wang PN, Shepherd S, Cheng CY, Dwyer MG, Hu HH, Zivadinov R. Jugular venous reflux and brain parenchyma volumes in elderly patients with mild cognitive impairment and Alzheimer's disease. Bmc Neurology. 13: 157. PMID 24176095 DOI: 10.1186/1471-2377-13-157 |
0.345 |
|
| 2013 |
Zivadinov R, Karmon Y, Dolic K, Hagemeier J, Marr K, Valnarov V, Kennedy CL, Hojnacki D, Carl EM, Hopkins LN, Levy EI, Weinstock-Guttman B, Siddiqui AH. Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study. Bmc Neurology. 13: 151. PMID 24139135 DOI: 10.1186/1471-2377-13-151 |
0.357 |
|
| 2013 |
Chaitanya GV, Omura S, Sato F, Martinez NE, Minagar A, Ramanathan M, Guttman BW, Zivadinov R, Tsunoda I, Alexander JS. Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature. Journal of Neuroinflammation. 10: 125. PMID 24124909 DOI: 10.1186/1742-2094-10-125 |
0.457 |
|
| 2013 |
Booth AJ, Rodgers JD, Schwartz CE, Quaranto BR, Weinstock-Guttman B, Zivadinov R, Benedict RH. Active cognitive reserve influences the regional atrophy to cognition link in multiple sclerosis. Journal of the International Neuropsychological Society : Jins. 19: 1128-33. PMID 24050681 DOI: 10.1017/S1355617713001082 |
0.637 |
|
| 2013 |
Wack DS, Dwyer MG, Bergsland N, Ramasamy D, Di Perri C, Ranza L, Hussein S, Magnano C, Seals K, Zivadinov R. Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI. Bmc Medical Imaging. 13: 29. PMID 24004511 DOI: 10.1186/1471-2342-13-29 |
0.427 |
|
| 2013 |
Karmon Y, Zivadinov R, Weinstock-Guttman B, Marr K, Valnarov V, Dolic K, Kennedy CL, Hojnacki D, Carl EM, Hagemeier J, Hopkins LN, Levy EI, Siddiqui AH. Comparison of intravascular ultrasound with conventional venography for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency. Journal of Vascular and Interventional Radiology : Jvir. 24: 1487-98.e1. PMID 23953830 DOI: 10.1016/J.Jvir.2013.06.012 |
0.401 |
|
| 2013 |
Benedict RH, Weinstock-Guttmam B, Marr K, Valnarov V, Kennedy C, Carl E, Brooks C, Hojnacki D, Zivadinov R. Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis. Bmc Medicine. 11: 167. PMID 23866161 DOI: 10.1186/1741-7015-11-167 |
0.636 |
|
| 2013 |
Dolic K, Siddiqui AH, Karmon Y, Marr K, Zivadinov R. The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants. Bmc Medicine. 11: 155. PMID 23806142 DOI: 10.1186/1741-7015-11-155 |
0.381 |
|
| 2013 |
Clifford DB, Nath A, Cinque P, Brew BJ, Zivadinov R, Gorelik L, Zhao Z, Duda P. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. Journal of Neurovirology. 19: 351-8. PMID 23733308 DOI: 10.1007/S13365-013-0173-Y |
0.301 |
|
| 2013 |
Zivadinov R, Shucard JL, Hussein S, Durfee J, Cox JL, Bergsland N, Dwyer MG, Benedict RH, Ambrus J, Shucard DW. Multimodal imaging in systemic lupus erythematosus patients with diffuse neuropsychiatric involvement. Lupus. 22: 675-83. PMID 23640981 DOI: 10.1177/0961203313486193 |
0.602 |
|
| 2013 |
Zivadinov R, Havrdová E, Bergsland N, Tyblova M, Hagemeier J, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Carl E, Kalincik T, Horáková D. Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple Sclerosis Radiology. 268: 831-841. PMID 23613615 DOI: 10.1148/Radiol.13122424 |
0.429 |
|
| 2013 |
Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, Lakota E, O'Connor K, Badgett D, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, et al. Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1186-91. PMID 23595944 DOI: 10.1136/Jnnp-2012-304740 |
0.316 |
|
| 2013 |
Kardys A, Weinstock-Guttman B, Dillon M, Masud MW, Weinstock N, Mahfooz N, Lang JK, Weinstock A, Lincoff N, Zivadinov R, Ramanathan M. Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis. European Journal of Neurology. 20: 1264-71. PMID 23581473 DOI: 10.1111/Ene.12162 |
0.314 |
|
| 2013 |
Zivadinov R, Bergsland N, Dolezal O, Hussein S, Seidl Z, Dwyer MG, Vaneckova M, Krasensky J, Potts JA, Kalincik T, Havrdová E, Horáková D. Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years. American Journal of Neuroradiology. 34: 1931-1939. PMID 23578679 DOI: 10.3174/Ajnr.A3503 |
0.422 |
|
| 2013 |
Zivadinov R, Magnano C, Galeotti R, Schirda C, Menegatti E, Weinstock-Guttman B, Marr K, Bartolomei I, Hagemeier J, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Beggs C, Salvi F, et al. Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case-control study. Journal of Vascular and Interventional Radiology. 24: 829-838. PMID 23523158 DOI: 10.1016/J.Jvir.2013.01.490 |
0.367 |
|
| 2013 |
Benedict RH, Schwartz CE, Duberstein P, Healy B, Hoogs M, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R. Influence of personality on the relationship between gray matter volume and neuropsychiatric symptoms in multiple sclerosis. Psychosomatic Medicine. 75: 253-61. PMID 23504242 DOI: 10.1097/Psy.0B013E31828837Cc |
0.652 |
|
| 2013 |
Benedict RH, Hulst HE, Bergsland N, Schoonheim MM, Dwyer MG, Weinstock-Guttman B, Geurts JJ, Zivadinov R. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1478-84. PMID 23459570 DOI: 10.1177/1352458513478675 |
0.643 |
|
| 2013 |
Zivadinov R, Treu CN, Weinstock-Guttman B, Turner C, Bergsland N, O'Connor K, Dwyer MG, Carl E, Ramasamy DP, Qu J, Ramanathan M. Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1075-81. PMID 23385850 DOI: 10.1136/Jnnp-2012-304661 |
0.373 |
|
| 2013 |
Zivadinov R, Tekwe C, Bergsland N, Dolezal O, Havrdova E, Krasensky J, Dwyer MG, Seidl Z, Ramasamy DP, Vaneckova M, Horakova D. Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study Multiple Sclerosis International. 2013: 231345-231345. PMID 23365753 DOI: 10.1155/2013/231345 |
0.453 |
|
| 2013 |
Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Qu J, Tamaño-Blanco M, Badgett D, Tyblova M, Bergsland N, Hussein S, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, et al. Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study. Plos One. 8: e53996. PMID 23320113 DOI: 10.1371/Journal.Pone.0053996 |
0.377 |
|
| 2013 |
Minagar A, Barnett MH, Benedict RH, Pelletier D, Pirko I, Sahraian MA, Frohman E, Zivadinov R. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology. 80: 210-9. PMID 23296131 DOI: 10.1212/Wnl.0B013E31827B910B |
0.685 |
|
| 2013 |
Hagemeier J, Weinstock-Guttman B, Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR, Kennedy C, Carl E, Dwyer MG, Minagar A, Zivadinov R. Gray matter SWI-filtered phase and atrophy are linked to disability in MS. Frontiers in Bioscience. 5: 525-532. PMID 23277008 DOI: 10.2741/E634 |
0.494 |
|
| 2013 |
Tipirneni A, Weinstock-Guttman B, Ramanathan M, Abdelrahman N, Hussein S, Hagemeier J, Durfee J, Teter BE, Hojnacki D, Dwyer MG, Zivadinov R. MRI characteristics of familial and sporadic multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1145-52. PMID 23232600 DOI: 10.1177/1352458512469697 |
0.464 |
|
| 2013 |
Hagemeier J, Yeh EA, Brown MH, Bergsland N, Dwyer MG, Carl E, Weinstock-Guttman B, Zivadinov R. Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 567-76. PMID 22968543 DOI: 10.1177/1352458512459289 |
0.4 |
|
| 2013 |
Di Perri C, Dwyer MG, Bergsland N, Schirda C, Poloni GU, Wack D, Cox JL, Dalaker TO, Ranza L, Zivadinov R, Saluste E, Hussein S, Bastianello S, Zivadinov R. White Matter Hyperintensities on 1.5 and 3 Tesla Brain MRI in Healthy Individuals Journal of Biomedical Graphics and Computing. 3. DOI: 10.5430/Jbgc.V3N3P53 |
0.322 |
|
| 2013 |
Schweser F, Dwyer MG, Deistung A, Reichenbach JR, Zivadinov R. Impact of tissue atrophy on high-pass filtered MRI signal phase-based assessment in large-scale group-comparison studies: a simulation study Frontiers in Physics. 1. DOI: 10.3389/Fphy.2013.00014 |
0.338 |
|
| 2012 |
Zivadinov R, Weinstock-Guttman B. Role of venoplasty for treatment of multiple sclerosis: value of open-label studies and surrogate treatment outcomes. Journal of Vascular and Interventional Radiology. 23: 1308-1310. PMID 22999749 DOI: 10.1016/J.Jvir.2012.08.009 |
0.302 |
|
| 2012 |
Zivadinov R, Ramanathan M, Ambrus J, Hussein S, Ramasamy DP, Dwyer MG, Bergsland N, Minagar A, Weinstock-Guttman B. Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study Neurological Research. 34: 761-769. PMID 22971466 DOI: 10.1179/1743132812Y.0000000076 |
0.423 |
|
| 2012 |
Karmon Y, Ramanathan M, Minagar A, Zivadinov R, Weinstock-Guttman B. Arterial, venous and other vascular risk factors in multiple sclerosis Neurological Research. 34: 754-760. PMID 22971465 DOI: 10.1179/1743132812Y.0000000077 |
0.463 |
|
| 2012 |
Zivadinov R, Alexander SJ, Minagar A. Vascular pathology of multiple sclerosis. Neurological Research. 34: 735-7. PMID 22971464 DOI: 10.1179/0161641212Z.000000000114 |
0.385 |
|
| 2012 |
Wack DS, Dwyer MG, Bergsland N, Di Perri C, Ranza L, Hussein S, Ramasamy D, Poloni G, Zivadinov R. Improved assessment of multiple sclerosis lesion segmentation agreement via detection and outline error estimates. Bmc Medical Imaging. 12: 17. PMID 22812697 DOI: 10.1186/1471-2342-12-17 |
0.33 |
|
| 2012 |
Zivadinov R, Hojnacki D, Hussein S, Bergsland N, Carl E, Durfee J, Dwyer MG, Kennedy C, Weinstock-Guttman B. Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study International Journal of Molecular Sciences. 13: 5659-5673. PMID 22754322 DOI: 10.3390/Ijms13055659 |
0.306 |
|
| 2012 |
Magnano C, Schirda C, Weinstock-Guttman B, Wack DS, Lindzen E, Hojnacki D, Bergsland N, Kennedy C, Belov P, Dwyer MG, Poloni GU, Beggs CB, Zivadinov R. Cine cerebrospinal fluid imaging in multiple sclerosis. Journal of Magnetic Resonance Imaging : Jmri. 36: 825-34. PMID 22733409 DOI: 10.1002/Jmri.23730 |
0.423 |
|
| 2012 |
Beggs CB, Shepherd SJ, Dwyer MG, Polak P, Magnano C, Carl E, Poloni GU, Weinstock-Guttman B, Zivadinov R. Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis. Neurological Research. 34: 793-801. PMID 22709857 DOI: 10.1179/1743132812Y.0000000048 |
0.475 |
|
| 2012 |
Weinstock-Guttman B, Ramanathan M, Marr K, Hojnacki D, Benedict RH, Morgan C, Yeh EA, Carl E, Kennedy C, Reuther J, Brooks C, Hunt K, Elfadil M, Andrews M, Zivadinov R. Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis. Bmc Neurology. 12: 26. PMID 22587224 DOI: 10.1186/1471-2377-12-26 |
0.659 |
|
| 2012 |
Zivadinov R, Cutter G, Marr K, Ramanathan M, Benedict RH, Bergsland N, Morgan C, Carl E, Hojnacki D, Yeh EA, Willis L, Cherneva M, Kennedy C, Dwyer MG, Weinstock-Guttman B. No association between conventional brain MR imaging and chronic cerebrospinal venous insufficiency in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 33: 1913-7. PMID 22576891 DOI: 10.3174/Ajnr.A3112 |
0.654 |
|
| 2012 |
Bergsland N, Horakova D, Dwyer MG, Dolezal O, Seidl ZK, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R. Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis American Journal of Neuroradiology. 33: 1573-1578. PMID 22499842 DOI: 10.3174/Ajnr.A3086 |
0.423 |
|
| 2012 |
Hagemeier J, Weinstock-Guttman B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Magnano C, Hojnacki D, Dwyer MG, Zivadinov R. Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy American Journal of Neuroradiology. 33: 1596-1601. PMID 22460343 DOI: 10.3174/Ajnr.A3030 |
0.388 |
|
| 2012 |
Hagemeier J, Heininen‐Brown M, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Weinstock‐Guttman B, Dwyer MG, Zivadinov R. Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study. Journal of Magnetic Resonance Imaging. 36: 73-83. PMID 22407571 DOI: 10.1002/Jmri.23603 |
0.38 |
|
| 2012 |
Zivadinov R, Pirko I. Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis? Bmc Neurology. 12: 9-9. PMID 22394621 DOI: 10.1186/1471-2377-12-9 |
0.508 |
|
| 2012 |
Pirko I, Cardin R, Chen Y, Lohrey AK, Lindquist DM, Dunn RS, Zivadinov R, Johnson AJ. CMV Infection Attenuates the Disease Course in a Murine Model of Multiple Sclerosis Plos One. 7. PMID 22393447 DOI: 10.1371/Journal.Pone.0032767 |
0.349 |
|
| 2012 |
Foster M, Zivadinov R, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Carl E, Ramanathan M. Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis. Journal of Neuroimmunology. 243: 61-68. PMID 22261546 DOI: 10.1016/J.Jneuroim.2011.12.007 |
0.465 |
|
| 2012 |
Zivadinov R, Hussein S, Bergsland N, Minagar A, Dwyer MG. Magnetization transfer imaging of acute black holes in patients on glatiramer acetate. Frontiers in Bioscience. 4: 1496-1504. PMID 22201970 DOI: 10.2741/475 |
0.336 |
|
| 2012 |
Dolic K, Marr K, Valnarov V, Dwyer MG, Carl E, Karmon Y, Kennedy C, Brooks C, Kilanowski C, Hunt K, Siddiqui AH, Hojnacki D, Weinstock-Guttman B, Zivadinov R. Intra- and extraluminal structural and functional venous anomalies in multiple sclerosis, as evidenced by 2 noninvasive imaging techniques American Journal of Neuroradiology. 33: 16-23. PMID 22194367 DOI: 10.3174/Ajnr.A2877 |
0.482 |
|
| 2012 |
Zivadinov R, Dwyer MG, Hussein S, Carl E, Kennedy C, Andrews M, Hojnacki D, Heininen-Brown M, Willis L, Cherneva M, Bergsland N, Weinstock-Guttman B. Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1125-34. PMID 22194217 DOI: 10.1177/1352458511433304 |
0.373 |
|
| 2012 |
Zivadinov R, Salvi F, Weinstock-Guttman B. Regarding CCSVI and MS: a never-ending story or a new chapter? European Journal of Vascular and Endovascular Surgery. 43: 129-130. PMID 22177011 DOI: 10.1016/J.Ejvs.2011.10.011 |
0.413 |
|
| 2012 |
Polak P, Magnano C, Zivadinov R, Poloni G. 3D FLAIRED: 3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis Magnetic Resonance in Medicine. 68: 874-881. PMID 22139997 DOI: 10.1002/Mrm.23289 |
0.345 |
|
| 2012 |
Habib CA, Liu M, Bawany N, Garbern J, Krumbein I, Mentzel HJ, Reichenbach J, Magnano C, Zivadinov R, Haacke EM. Assessing abnormal iron content in the deep gray matter of patients with multiple sclerosis versus healthy controls. Ajnr. American Journal of Neuroradiology. 33: 252-8. PMID 22116106 DOI: 10.3174/Ajnr.A2773 |
0.39 |
|
| 2012 |
O’Connor K, Weinstock-Guttman B, Carl E, Kilanowski C, Zivadinov R, Ramanathan M. Patterns of dietary and herbal supplement use by multiple sclerosis patients. Journal of Neurology. 259: 637-644. PMID 21898138 DOI: 10.1007/S00415-011-6226-3 |
0.475 |
|
| 2012 |
Zamboni P, Galeotti R, Weinstock-Guttman B, Kennedy C, Salvi F, Zivadinov R. Venous Angioplasty in Patients with Multiple Sclerosis: Results of a Pilot Study European Journal of Vascular and Endovascular Surgery. 43: 116-122. PMID 21839654 DOI: 10.1016/J.Ejvs.2011.03.035 |
0.462 |
|
| 2012 |
Zivadinov R, Heininen-Brown M, Schirda CV, Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E, Hagemeier J, Benedict RH, Weinstock-Guttman B, Dwyer MG. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage. 59: 331-9. PMID 21820063 DOI: 10.1016/J.Neuroimage.2011.07.045 |
0.651 |
|
| 2012 |
Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. Journal of Neurology. 259: 139-46. PMID 21720932 DOI: 10.1007/S00415-011-6147-1 |
0.664 |
|
| 2012 |
Hagemeier J, Yeh EA, Heininen-Brown M, Bergsland N, Dwyer M, Carl E, Weinstock-Guttman B, Zivadinov R. Iron Deposition in the Subcortical Deep-Gray Matter of Pediatric Multiple Sclerosis Patients (S50.006) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S50.006 |
0.378 |
|
| 2012 |
Zivadinov R, Hagemeier J, Heininen-Brown M, Poloni G, Bergsland N, Schirda C, Magnano C, Kennedy C, Carl E, Dwyer M, Weinstock-Guttman B. Subcortical Deep Gray Matter SWI-Filtered Phase and Atrophy Are Associated with Disability in MS (S21.005) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S21.005 |
0.399 |
|
| 2012 |
Hojnacki D, Zivadinov R, Weinstock-Guttman B. Successful Treatment of Natalizumab Induced PML with CMX001 and the Side Effects Associated with Its Use (P07.060) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.060 |
0.37 |
|
| 2012 |
Hojnacki D, Zivadinov R, Weinstock-Guttman B. Subtle Lesion Appearance on MRI May Precede Development of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients Treated with Natalizumab (P07.059) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.059 |
0.378 |
|
| 2012 |
Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, Brooks C, Kilanowski C, Ramanathan M, Zivadinov R. Risk Factors for Chronic Cerebrospinal Venous Insufficiency (CCSVI) (P05.127) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.127 |
0.405 |
|
| 2012 |
Zivadinov R, Bergsland N, Dolezal O, Hussein S, Seidl Z, Dwyer M, Vaneckova M, Krasensky J, Potts J, Havrdova E, Horakova D. Subcortical but Not Cortical Gray Matter Atrophy Predicts Disability Progression over 5 Years in Patients with Early Relapsing-Remitting Multiple Sclerosis (P03.063) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.063 |
0.462 |
|
| 2012 |
Livshits I, Hussein S, Kennedy C, Weinstock-Guttman B, Hojnacki D, Zivadinov R. Comparison of a 1.5T Standard vs. 3T Optimized Protocols in Multiple Sclerosis Patients (P03.053) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.053 |
0.394 |
|
| 2012 |
Dwyer M, Heininen-Brown M, Hagemeier J, Poloni G, Bergsland N, Magnano C, Durfee J, Kennedy C, Carl E, Weinstock-Guttman B, Zivadinov R. Iron Deposition in Multiple Sclerosis Lesions Measured by Susceptibility-Weighted Imaging Filtered Phase. A Case Control Study (P03.042) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.042 |
0.334 |
|
| 2011 |
Dake MD, Zivadinov R, Haacke EM. Chronic cerebrospinal venous insufficiency in multiple sclerosis: a historical perspective. Functional Neurology. 26: 181-95. PMID 22364939 |
0.393 |
|
| 2011 |
Dolic K, Weinstock-Guttman B, Marr K, Valnarov V, Carl E, Hagemeier J, Brooks C, Kilanowski C, Hojnacki D, Ramanathan M, Zivadinov R. Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. Plos One. 6. PMID 22140507 DOI: 10.1371/Journal.Pone.0028062 |
0.357 |
|
| 2011 |
Covey TJ, Zivadinov R, Shucard JL, Shucard DW. Information processing speed, neural efficiency, and working memory performance in multiple sclerosis: differential relationships with structural magnetic resonance imaging. Journal of Clinical and Experimental Neuropsychology. 33: 1129-45. PMID 22047454 DOI: 10.1080/13803395.2011.614597 |
0.474 |
|
| 2011 |
Zivadinov R, Marr K. Comment on "Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS?". Neurology. 77: 1710; author reply 1. PMID 22042799 DOI: 10.1212/WNL.0b013e318230b225 |
0.303 |
|
| 2011 |
Zivadinov R, Poloni GU, Marr K, Schirda CV, Magnano CR, Carl E, Bergsland N, Hojnacki D, Kennedy C, Beggs CB, Dwyer MG, Weinstock-Guttman B. Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency. Bmc Neurology. 11: 128. PMID 22011402 DOI: 10.1186/1471-2377-11-128 |
0.474 |
|
| 2011 |
Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, Teter B, Hussein S, Mehta B, Weiskopf M, Durfee J, Bergsland N, Ramanathan M. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. Journal of Neuroinflammation. 8: 127. PMID 21970791 DOI: 10.1186/1742-2094-8-127 |
0.397 |
|
| 2011 |
Zivadinov R, Ramanathan M, Dolic K, Marr K, Karmon Y, Siddiqui AH, Benedict RH, Weinstock-Guttman B. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives. Expert Review of Neurotherapeutics. 11: 1277-94. PMID 21864074 DOI: 10.1586/Ern.11.117 |
0.609 |
|
| 2011 |
Weinstock-Guttman B, Zivadinov R, Ramanathan M. Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis Journal of the Neurological Sciences. 311: 86-91. PMID 21849177 DOI: 10.1016/J.Jns.2011.07.024 |
0.354 |
|
| 2011 |
Poloni G, Minagar A, Haacke EM, Zivadinov R. Recent developments in imaging of multiple sclerosis. The Neurologist. 17: 185-204. PMID 21712664 DOI: 10.1097/Nrl.0B013E31821A2643 |
0.467 |
|
| 2011 |
Zivadinov R, Weinstock-Guttman B, Pirko I. Iron deposition and inflammation in multiple sclerosis. Which one comes first Bmc Neuroscience. 12: 60-60. PMID 21699686 DOI: 10.1186/1471-2202-12-60 |
0.367 |
|
| 2011 |
Zivadinov R, Ramanathan M, Dwyer MG, Marr K, Benedict RH, Weinstock-Guttman B. Comment on "no evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset". Annals of Neurology. 69: 1062-3; author reply. PMID 21681801 DOI: 10.1002/Ana.22420 |
0.595 |
|
| 2011 |
Horakova D, Zivadinov R, Weinstock-Guttman B, Havrdova E, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Lelkova P, Ramanathan M. HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating event. Journal of Neuroimmunology. 236: 76-80. PMID 21621859 DOI: 10.1016/J.Jneuroim.2011.04.011 |
0.439 |
|
| 2011 |
Benedict RH, Zivadinov R. Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nature Reviews. Neurology. 7: 332-42. PMID 21556031 DOI: 10.1038/Nrneurol.2011.61 |
0.632 |
|
| 2011 |
Zivadinov R, Marr K, Cutter G, Ramanathan M, Benedict RH, Kennedy C, Elfadil M, Yeh AE, Reuther J, Brooks C, Hunt K, Andrews M, Carl E, Dwyer MG, Hojnacki D, et al. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology. 77: 138-44. PMID 21490322 DOI: 10.1212/Wnl.0B013E318212A901 |
0.634 |
|
| 2011 |
Zivadinov R, Galeotti R, Hojnacki D, Menegatti E, Dwyer MG, Schirda C, Malagoni AM, Marr K, Kennedy C, Bartolomei I, Magnano C, Salvi F, Weinstock-Guttman B, Zamboni P. Value of MR venography for detection of internal jugular vein anomalies in multiple sclerosis: a pilot longitudinal study. American Journal of Neuroradiology. 32: 938-946. PMID 21474626 DOI: 10.3174/Ajnr.A2386 |
0.461 |
|
| 2011 |
Zamboni P, Menegatti E, Weinstock-Guttman B, Dwyer MG, Schirda CV, Malagoni AM, Hojnacki D, Kennedy C, Carl E, Bergsland N, Magnano C, Bartolomei I, Salvi F, Zivadinov R. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report Bmc Medicine. 9: 22-22. PMID 21385345 DOI: 10.1186/1741-7015-9-22 |
0.526 |
|
| 2011 |
Weinstock-Guttman B, Zivadinov R, Cutter G, Tamaño-Blanco M, Marr K, Badgett D, Carl E, Elfadil M, Kennedy C, Benedict RH, Ramanathan M. Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients. Plos One. 6: e16802. PMID 21340025 DOI: 10.1371/Journal.Pone.0016802 |
0.642 |
|
| 2011 |
Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, Kennedy CL, Brooks CL, Reuther JA, Hunt K, Andrews M, Dwyer MG, Hojnacki DW. Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology. 258: 562-70. PMID 21177394 DOI: 10.1148/Radiol.10101387 |
0.443 |
|
| 2011 |
Valerio M, Liu HB, Heffner R, Zivadinov R, Ramanathan M, Weinstock-Guttman B, Awad AB. Phytosterols ameliorate clinical manifestations and inflammation in experimental autoimmune encephalomyelitis. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 60: 457-65. PMID 21136279 DOI: 10.1007/S00011-010-0288-Z |
0.432 |
|
| 2011 |
Weinstock-Guttman B, Zivadinov R, Qu J, Cookfair D, Duan X, Bang E, Bergsland N, Hussein S, Cherneva M, Willis L, Heininen-Brown M, Ramanathan M. Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 189-95. PMID 21047880 DOI: 10.1136/Jnnp.2010.227942 |
0.422 |
|
| 2011 |
Alexander JS, Zivadinov R, Maghzi AH, Ganta VC, Harris MK, Minagar A. Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms. Pathophysiology : the Official Journal of the International Society For Pathophysiology / Isp. 18: 3-12. PMID 20663648 DOI: 10.1016/J.Pathophys.2010.04.002 |
0.451 |
|
| 2011 |
Weinstock-Guttman B, Benedict RH, Tamaño-Blanco M, Ramasamy DP, Stosic M, Polito J, Zivadinov R, Ramanathan M. The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis. Pathophysiology : the Official Journal of the International Society For Pathophysiology / Isp. 18: 43-52. PMID 20547043 DOI: 10.1016/J.Pathophys.2010.04.005 |
0.595 |
|
| 2011 |
Zivadinov R, Hussein S, Stosic M, Durfee J, Cox JL, Cookfair DL, Hashmi K, Abdelrahman N, Garg N, Dwyer MG, Weinstock-Guttman B. Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis. A case-control diffusion imaging study. Pathophysiology : the Official Journal of the International Society For Pathophysiology / Isp. 18: 61-8. PMID 20510590 DOI: 10.1016/J.Pathophys.2010.04.007 |
0.478 |
|
| 2011 |
Ramasamy DP, Ramanathan M, Cox JL, Antulov R, Weinstock-Guttman B, Bergsland N, Benedict RH, Dwyer MG, Minagar A, Zivadinov R. Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study. Pathophysiology : the Official Journal of the International Society For Pathophysiology / Isp. 18: 53-60. PMID 20478698 DOI: 10.1016/J.Pathophys.2010.04.006 |
0.631 |
|
| 2011 |
Antulov R, Carone DA, Bruce J, Yella V, Dwyer MG, Tjoa CW, Benedict RH, Zivadinov R. Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 21: 210-8. PMID 20412395 DOI: 10.1111/J.1552-6569.2010.00482.X |
0.613 |
|
| 2011 |
Zivadinov R, Hussein S, Stosic M, Durfee J, Cox JL, Hashmi K, Abdelrahman N, Garg N, Dwyer MG, Weinstock-Guttman B. Corrigendum to “Glatiramer acetate recovers microscopic tissue damage in patients with multiple sclerosis: A case–control diffusion imaging study” [Pathophysiology 18 (2011) 61–68] Pathophysiology. 18: 335. DOI: 10.1016/J.Pathophys.2011.07.001 |
0.356 |
|
| 2010 |
Frohman EM, Cutter G, Remington G, Gao H, Rossman H, Weinstock-Guttman B, Durfee JE, Conger A, Carl E, Treadaway K, Lindzen E, Salter A, Frohman TC, Shah A, Bates A, ... ... Zivadinov R, et al. A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders. 3: 15-28. PMID 21180633 DOI: 10.1177/1756285609353354 |
0.403 |
|
| 2010 |
Morrow SA, Drake A, Zivadinov R, Munschauer F, Weinstock-Guttman B, Benedict RH. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. The Clinical Neuropsychologist. 24: 1131-45. PMID 20830649 DOI: 10.1080/13854046.2010.511272 |
0.618 |
|
| 2010 |
Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, Apatoff B, Coyle P, Goodman AD, Gottesman M, Granger C, Jubelt B, Krupp L, Lenihan M, Lublin F, Mihai C, ... ... Zivadinov R, et al. Rapid disease course in African Americans with multiple sclerosis. Neurology. 75: 217-23. PMID 20644149 DOI: 10.1212/Wnl.0B013E3181E8E72A |
0.454 |
|
| 2010 |
Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, Bronnick K, Tysnes OB, Antulov R, Dwyer MG, Aarsland D. Gray matter correlations of cognition in incident Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 629-33. PMID 20213820 DOI: 10.1002/Mds.22867 |
0.329 |
|
| 2010 |
Horstman LL, Jy W, Ahn YS, Zivadinov R, Maghzi AH, Etemadifar M, Steven Alexander J, Minagar A. Role of platelets in neuroinflammation: a wide-angle perspective. Journal of Neuroinflammation. 7: 10. PMID 20128908 DOI: 10.1186/1742-2094-7-10 |
0.305 |
|
| 2010 |
Minagar A, Alexander JS, Sahraian MA, Zivadinov R. Alemtuzumab and multiple sclerosis: Therapeutic application Expert Opinion On Biological Therapy. 10: 421-429. PMID 20095876 DOI: 10.1517/14712591003586806 |
0.345 |
|
| 2010 |
Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG, Hussein S, Bergsland N, Munschauer FE, Zivadinov R. Increased tissue damage and lesion volumes in African Americans with multiple sclerosis Neurology. 74: 538-544. PMID 20089944 DOI: 10.1212/Wnl.0B013E3181Cff6Fb |
0.478 |
|
| 2010 |
Stosic M, Ambrus J, Garg N, Weinstock-Guttman B, Ramanathan M, Kalman B, Minagar A, Munschauer FE, Galey TM, Hussein S, Bakshi R, Zivadinov R. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis. Journal of Neurology. 257: 63-71. PMID 19633967 DOI: 10.1007/S00415-009-5264-6 |
0.503 |
|
| 2010 |
Zamboni P, Galeotti R, Weinstock-Guttman B, Cutter G, Menegatti E, Malagoni AM, Bartolomei I, Cox JL, Salvi F, Zivadinov R. Endovascular Treatment for Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Longitudinal, Magnetic Resonance Imaging, Blinded Pilot Study Journal of Vascular Surgery. 51: 794. DOI: 10.1016/J.Jvs.2009.11.022 |
0.351 |
|
| 2009 |
Yeh EA, Weinstock-Guttman B, Ramanathan M, Ramasamy DP, Willis L, Cox JL, Zivadinov R. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain : a Journal of Neurology. 132: 3392-400. PMID 19892770 DOI: 10.1093/Brain/Awp278 |
0.469 |
|
| 2009 |
Dalaker TO, Larsen JP, Bergsland N, Beyer MK, Alves G, Dwyer MG, Tysnes OB, Benedict RH, Kelemen A, Bronnick K, Zivadinov R. Brain atrophy and white matter hyperintensities in early Parkinson's disease(a). Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2233-41. PMID 19768730 DOI: 10.1002/Mds.22754 |
0.575 |
|
| 2009 |
Pirko I, Zivadinov R. Transcranial sonography of deep gray nuclei: a new outcome measure in multiple sclerosis? Neurology. 73: 1006-1007. PMID 19710403 DOI: 10.1212/Wnl.0B013E3181Bb1De9 |
0.466 |
|
| 2009 |
Zivadinov R, Weinstock-Guttman B, Hashmi K, Abdelrahman N, Stosic M, Dwyer M, Hussein S, Durfee J, Ramanathan M. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis Neurology. 73: 504-510. PMID 19687451 DOI: 10.1212/Wnl.0B013E3181B2A706 |
0.381 |
|
| 2009 |
Dalaker TO, Larsen JP, Dwyer MG, Aarsland D, Beyer MK, Alves G, Bronnick K, Tysnes OB, Zivadinov R. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease. Neuroimage. 47: 2083-9. PMID 19539037 DOI: 10.1016/J.Neuroimage.2009.06.020 |
0.308 |
|
| 2009 |
Perri CD, Dalaker TO, Beyer MK, Zivadinov R. Chapter 4 Neuroimaging of Cognitive Impairments in Vascular Disease International Review of Neurobiology. 84: 49-80. PMID 19501713 DOI: 10.1016/S0074-7742(09)00404-8 |
0.306 |
|
| 2009 |
Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, et al. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 965-76. PMID 19465443 DOI: 10.1177/1352458509105229 |
0.377 |
|
| 2009 |
Dwyer M, Bergsland N, Hussein S, Durfee J, Wack D, Zivadinov R. A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio Journal of the Neurological Sciences. 282: 86-95. PMID 19386319 DOI: 10.1016/J.Jns.2009.03.016 |
0.436 |
|
| 2009 |
Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E, Hussein S, Schirda C, Stosic M, Durfee J, Poloni GU, Nayyar N, Bergamaschi R, Zivadinov R. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study. Neuroimage. 47: 1352-62. PMID 19371784 DOI: 10.1016/J.Neuroimage.2009.04.019 |
0.352 |
|
| 2009 |
Zivadinov R. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials. Methods and Findings in Experimental and Clinical Pharmacology. 31: 29-40. PMID 19357796 DOI: 10.1358/Mf.2009.31.1.1328632 |
0.456 |
|
| 2009 |
Zivadinov R, Minagar A. Evidence for gray matter pathology in multiple sclerosis: a neuroimaging approach. Journal of the Neurological Sciences. 282: 1-4. PMID 19345379 DOI: 10.1016/J.Jns.2009.03.014 |
0.506 |
|
| 2009 |
Geurts JJ, Stys PK, Minagar A, Amor S, Zivadinov R. Gray matter pathology in (chronic) MS: modern views on an early observation. Journal of the Neurological Sciences. 282: 12-20. PMID 19249061 DOI: 10.1016/J.Jns.2009.01.018 |
0.505 |
|
| 2009 |
Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. Journal of Neuroimmunology. 209: 123-30. PMID 19232441 DOI: 10.1016/J.Jneuroim.2009.01.023 |
0.369 |
|
| 2009 |
Ramasamy DP, Benedict RH, Cox JL, Fritz D, Abdelrahman N, Hussein S, Minagar A, Dwyer MG, Zivadinov R. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. Journal of the Neurological Sciences. 282: 47-54. PMID 19201003 DOI: 10.1016/J.Jns.2008.12.034 |
0.669 |
|
| 2009 |
Zivadinov R, Zorzon M, Weinstock-Guttman B, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M. Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 80: 620-5. PMID 19168469 DOI: 10.1136/Jnnp.2008.154906 |
0.454 |
|
| 2009 |
Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. Journal of the Neurological Sciences. 282: 112-9. PMID 19168190 DOI: 10.1016/J.Jns.2008.12.005 |
0.429 |
|
| 2009 |
Antulov R, Weinstock-Guttman B, Cox JL, Hussein S, Durfee J, Caiola C, Dwyer MG, Bergsland N, Abdelrahman N, Stosic M, Hojnacki D, Munschauer FE, Miletic D, Zivadinov R. Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 345-54. PMID 19028830 DOI: 10.1177/1352458508099479 |
0.476 |
|
| 2009 |
Benedict RH, Ramasamy D, Munschauer F, Weinstock-Guttman B, Zivadinov R. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 80: 201-6. PMID 18829629 DOI: 10.1136/Jnnp.2008.148403 |
0.623 |
|
| 2008 |
Salter AR, Conger A, Frohman TC, Zivadinov R, Eggenberger E, Calabresi P, Cutter G, Balcer L, Frohman EM. Retinal architecture predicts pupillary reflex metrics in MS. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 479-86. PMID 19091882 DOI: 10.1177/1352458508100503 |
0.353 |
|
| 2008 |
Zivadinov R, Munschauer FE, Ramanathan M, Benedict RH, Weinstock-Guttman B. Clinical efficacy, effects on MRI and tolerability of weekly intramuscular interferon-beta-1a in patients with MS and CIS. Drugs of Today (Barcelona, Spain : 1998). 44: 601-13. PMID 18846271 DOI: 10.1358/Dot.2008.44.8.1242250 |
0.661 |
|
| 2008 |
Zivadinov R, Bergsland N, Stosic M, Sharma J, Nussenbaum F, Durfee J, Hani N, Abdelrahman N, Jaisani Z, Minagar A, Hoque R, Munschauer FE, Dwyer MG. Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis. Neurological Research. 30: 816-826. PMID 18826808 DOI: 10.1179/174313208X341003 |
0.346 |
|
| 2008 |
Weinstock-Guttman B, Ramanathan M, Zivadinov R. Interferon-β treatment for relapsing multiple sclerosis Expert Opinion On Biological Therapy. 8: 1435-1447. PMID 18694361 DOI: 10.1517/14712598.8.9.1435 |
0.364 |
|
| 2008 |
Zivadinov R, Reder AT, Filippi M, Minagar A, Stuve O, Lassmann H, Racke MK, Dwyer MG, Frohman E, Khan O. Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis Neurology. 71: 136-144. PMID 18606968 DOI: 10.1212/01.Wnl.0000316810.01120.05 |
0.417 |
|
| 2008 |
Benedict RH, Hussein S, Englert J, Dwyer MG, Abdelrahman N, Cox JL, Munschauer FE, Weinstock-Guttman B, Zivadinov R. Cortical atrophy and personality in multiple sclerosis. Neuropsychology. 22: 432-41. PMID 18590355 DOI: 10.1037/0894-4105.22.4.432 |
0.657 |
|
| 2008 |
Benedict RH, Shucard JL, Zivadinov R, Shucard DW. Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis. Neuropsychology Review. 18: 149-66. PMID 18521755 DOI: 10.1007/S11065-008-9061-2 |
0.666 |
|
| 2008 |
Sternberg Z, Weinstock-Guttman B, Hojnacki D, Zamboni P, Zivadinov R, Chadha K, Lieberman A, Kazim L, Drake A, Rocco P, Grazioli E, Munschauer F. Soluble receptor for advanced glycation end products in multiple sclerosis: a potential marker of disease severity. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 759-63. PMID 18505774 DOI: 10.1177/1352458507088105 |
0.44 |
|
| 2008 |
Zivadinov R, Stosic M, Cox JL, Ramasamy DP, Dwyer MG. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome. Journal of Neurology. 255: 61-74. PMID 18317678 DOI: 10.1007/S00415-008-1009-1 |
0.427 |
|
| 2008 |
Tjoa CW, Benedict RH, Dwyer MG, Carone DA, Zivadinov R. Regional specificity of magnetization transfer imaging in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 18: 130-6. PMID 18315593 DOI: 10.1111/J.1552-6569.2007.00198.X |
0.635 |
|
| 2008 |
Zivadinov R, Cox JL. Is functional MRI feasible for multi-center studies on multiple sclerosis? European Journal of Neurology. 15: 109-10. PMID 18217879 DOI: 10.1111/J.1468-1331.2007.02030.X |
0.421 |
|
| 2008 |
Frohman EM, Costello F, Stüve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L, Zivadinov R. Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. Archives of Neurology. 65: 26-35. PMID 18195137 DOI: 10.1001/Archneurol.2007.10 |
0.311 |
|
| 2008 |
Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM. Pharmacological treatment of early multiple sclerosis. Drugs. 68: 73-83. PMID 18081373 DOI: 10.2165/00003495-200868010-00005 |
0.452 |
|
| 2008 |
Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong JR, Hussein S, Cox JL, Hojnacki D, Ramanathan M. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. Journal of the Neurological Sciences. 268: 12-7. PMID 18054962 DOI: 10.1016/J.Jns.2007.10.020 |
0.431 |
|
| 2008 |
Brass SD, Zivadinov R, Bakshi R. Acute demyelinating optic neuritis: A review Frontiers in Bioscience. 13: 2376-2390. PMID 17981719 DOI: 10.2741/2851 |
0.472 |
|
| 2008 |
Zivadinov R, Banas AC, Yella V, Abdelrahman N, Weinstock-Guttman B, Dwyer MG. Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis. American Journal of Neuroradiology. 29: 319-325. PMID 17974604 DOI: 10.3174/Ajnr.A0813 |
0.432 |
|
| 2008 |
Zivadinov R, Zorzon M, Masi RD, Nasuelli D, Cazzato G. Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences. 267: 28-35. PMID 17945260 DOI: 10.1016/J.Jns.2007.09.025 |
0.38 |
|
| 2008 |
Horakova D, Cox JL, Havrdova E, Hussein S, Dolezal O, Cookfair D, Dwyer MG, Seidl Z, Bergsland N, Vaneckova M, Zivadinov R. Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 407-14. PMID 17550987 DOI: 10.1136/Jnnp.2007.120378 |
0.489 |
|
| 2007 |
Frohman EM, Zivadinov R. What you see is what you get Coupling function with structure in the visual system Neurology. 69: 2119-2120. PMID 18056576 DOI: 10.1212/01.Wnl.0000286935.08884.5F |
0.432 |
|
| 2007 |
Shah A, Eggenberger E, Zivadinov R, Stüve O, Frohman EM. Corticosteroids for multiple sclerosis: II. Application for disease-modifying effects Neurotherapeutics. 4: 627-632. PMID 17920543 DOI: 10.1016/J.Nurt.2007.07.009 |
0.401 |
|
| 2007 |
Frohman EM, Shah A, Eggenberger E, Metz L, Zivadinov R, Stüve O. Corticosteroids for multiple sclerosis: I. Application for treating exacerbations. Neurotherapeutics. 4: 618-626. PMID 17920542 DOI: 10.1016/J.Nurt.2007.07.008 |
0.43 |
|
| 2007 |
Zivadinov R, Weinstock-Guttman B, Benedict R, Tamaño-Blanco M, Hussein S, Abdelrahman N, Durfee J, Ramanathan M. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Human Molecular Genetics. 16: 2659-68. PMID 17656372 DOI: 10.1093/Hmg/Ddm189 |
0.614 |
|
| 2007 |
Weinstock-Guttman B, Zivadinov R. New MRI criteria in the diagnosis of multiple sclerosis. Lancet Neurology. 6: 664-665. PMID 17638605 DOI: 10.1016/S1474-4422(07)70181-3 |
0.394 |
|
| 2007 |
Benedict RH, Bruce J, Dwyer MG, Weinstock-Guttman B, Tjoa C, Tavazzi E, Munschauer FE, Zivadinov R. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 722-30. PMID 17613599 DOI: 10.1177/1352458507075592 |
0.642 |
|
| 2007 |
Weinstock-Guttman B, Zivadinov R, Tamaño-Blanco M, Abdelrahman N, Badgett D, Durfee J, Hussein S, Feichter J, Patrick K, Benedict R, Ramanathan M. Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. Journal of Neuroimmunology. 188: 167-74. PMID 17602759 DOI: 10.1016/J.Jneuroim.2007.06.003 |
0.629 |
|
| 2007 |
Zivadinov R. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis Neurology. 68. PMID 17548573 DOI: 10.1212/01.Wnl.0000275236.51129.D2 |
0.468 |
|
| 2007 |
Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. International Review of Neurobiology. 79: 521-35. PMID 17531857 DOI: 10.1016/S0074-7742(07)79023-2 |
0.46 |
|
| 2007 |
Hoque R, Ledbetter C, Gonzalez-Toledo E, Misra V, Menon U, Kenner M, Rabinstein AA, Kelley RE, Zivadinov R, Minagar A. The Role of Quantitative Neuroimaging Indices in the Differentiation of Ischemia From Demyelination: An Analytical Study With Case Presentation International Review of Neurobiology. 79: 491-519. PMID 17531856 DOI: 10.1016/S0074-7742(07)79022-0 |
0.359 |
|
| 2007 |
Dolezal O, Dwyer MG, Horakova D, Havrdova E, Minagar A, Balachandran S, Bergsland N, Seidl Z, Vaneckova M, Fritz D, Krasensky J, Zivadinov R. Detection of cortical lesions is dependent on choice of slice thickness in patients with multiple sclerosis. International Review of Neurobiology. 79: 475-89. PMID 17531855 DOI: 10.1016/S0074-7742(07)79021-9 |
0.386 |
|
| 2007 |
Zivadinov R, Cox JL. Neuroimaging in multiple sclerosis. International Review of Neurobiology. 79: 449-74. PMID 17531854 DOI: 10.1016/S0074-7742(07)79020-7 |
0.464 |
|
| 2007 |
Tekok-Kilic A, Benedict RH, Weinstock-Guttman B, Dwyer MG, Carone D, Srinivasaraghavan B, Yella V, Abdelrahman N, Munschauer F, Bakshi R, Zivadinov R. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage. 36: 1294-300. PMID 17524670 DOI: 10.1016/J.Neuroimage.2007.04.017 |
0.624 |
|
| 2007 |
Garg N, Zivadinov R, Ramanathan M, Vasiliu I, Locke J, Watts K, Lema J, Rajeswary J, Munschauer FE, Ambrus J, Weinstock-Guttman B. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients. Journal of Neuroimmunology. 187: 159-165. PMID 17512610 DOI: 10.1016/J.Jneuroim.2007.04.008 |
0.441 |
|
| 2007 |
Benedict RH, Zivadinov R. Reliability and validity of neuropsychological screening and assessment strategies in MS. Journal of Neurology. 254: II22-II25. PMID 17503124 DOI: 10.1007/S00415-007-2007-4 |
0.64 |
|
| 2007 |
Tavazzi E, Dwyer MG, Weinstock-Guttman B, Lema J, Bastianello S, Bergamaschi R, Cosi V, Benedict RH, Munschauer FE, Zivadinov R. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Neuroimage. 36: 746-54. PMID 17498974 DOI: 10.1016/J.Neuroimage.2007.03.056 |
0.659 |
|
| 2007 |
Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. Multiple Sclerosis (Houndmills, Basingstoke, England). 13: 490-501. PMID 17463072 DOI: 10.1177/1352458506070446 |
0.486 |
|
| 2007 |
Parmenter BA, Zivadinov R, Kerenyi L, Gavett R, Weinstock-Guttman B, Dwyer MG, Garg N, Munschauer F, Benedict RH. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) Sorting Tests in multiple sclerosis. Journal of Clinical and Experimental Neuropsychology. 29: 215-23. PMID 17365256 DOI: 10.1080/13803390600672163 |
0.653 |
|
| 2007 |
Weinstock-Guttman B, Tamaño-Blanco M, Bhasi K, Zivadinov R, Ramanathan M. Pharmacogenetics of MXA SNPs in interferon-β treated multiple sclerosis patients Journal of Neuroimmunology. 182: 236-239. PMID 17126411 DOI: 10.1016/J.Jneuroim.2006.10.011 |
0.365 |
|
| 2006 |
Chadha K, Weinstock-Guttman B, Zivadinov R, Bhasi K, Muhitch J, Feichter J, Tamaño-Blanco M, Abdelrahman N, Ambrus J, Munschauer F, Ramanathan M. Interferon inhibitory activity in patients with multiple sclerosis. Archives of Neurology. 63: 1579-84. PMID 17101826 DOI: 10.1001/Archneur.63.11.1579 |
0.413 |
|
| 2006 |
Sharma J, Zivadinov R, Jaisani Z, Fabiano AJ, Singh B, Horsfield MA, Bakshi R. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 16: 302-10. PMID 17032378 DOI: 10.1111/J.1552-6569.2006.00054.X |
0.51 |
|
| 2006 |
Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T, Balcer L. Optical coherence tomography in multiple sclerosis. Lancet Neurology. 5: 853-863. PMID 16987732 DOI: 10.1016/S1474-4422(06)70573-7 |
0.379 |
|
| 2006 |
Benedict RH, Bruce JM, Dwyer MG, Abdelrahman N, Hussein S, Weinstock-Guttman B, Garg N, Munschauer F, Zivadinov R. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Archives of Neurology. 63: 1301-6. PMID 16966509 DOI: 10.1001/Archneur.63.9.1301 |
0.686 |
|
| 2006 |
Santos R, Weinstock-Guttman B, Tamaño-Blanco M, Badgett D, Zivadinov R, Justinger T, Munschauer F, Ramanathan M. Dynamics of interferon-β modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-β neutralizing antibodies Journal of Neuroimmunology. 176: 125-133. PMID 16698090 DOI: 10.1016/J.Jneuroim.2006.03.019 |
0.306 |
|
| 2006 |
Fritz DA, Dwyer MG, Bagnato F, Watts KL, Bratina A, Zorzon M, Durastanti V, Locatelli L, Millefiorini E, Zivadinov R. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. Neurological Research. 28: 275-9. PMID 16687053 DOI: 10.1179/016164106X98152 |
0.454 |
|
| 2006 |
Zivadinov R, Nasuelli D, Tommasi MA, Serafin M, Bratina A, Ukmar M, Pirko I, Johnson AJ, Furlan C, Pozzi-Mucelli RS, Monti-Bragadin L, Grop A, Zambon M, Antonello RM, Cazzato G, et al. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurological Research. 28: 262-269. PMID 16687051 DOI: 10.1179/016164106X98134 |
0.434 |
|
| 2006 |
Carone DA, Benedict RH, Zivadinov R, Singh B, Ambrus JL. Progressive cerebral disease in lymphomatoid granulomatosis causes anterograde amnesia and neuropsychiatric disorder. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 16: 163-6. PMID 16629740 DOI: 10.1111/J.1552-6569.2006.00019.X |
0.601 |
|
| 2006 |
Benedict RH, Zivadinov R. Predicting neuropsychological abnormalities in multiple sclerosis. Journal of the Neurological Sciences. 245: 67-72. PMID 16626751 DOI: 10.1016/J.Jns.2005.05.020 |
0.65 |
|
| 2006 |
Frohman EM, Havrdova E, Lublin F, Barkhof F, Achiron A, Sharief MK, Stuve O, Racke MK, Steinman L, Weiner H, Olek M, Zivadinov R, Corboy J, Raine C, Cutter G, et al. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Archives of Neurology. 63: 614-9. PMID 16606781 DOI: 10.1001/Archneur.63.4.614 |
0.413 |
|
| 2006 |
Tekok-Kilic A, Benedict RH, Zivadinov R. Update on the relationships between neuropsychological dysfunction and structural MRI in multiple sclerosis. Expert Review of Neurotherapeutics. 6: 323-31. PMID 16533137 DOI: 10.1586/14737175.6.3.323 |
0.676 |
|
| 2006 |
Carone DA, Benedict RH, Dwyer MG, Cookfair DL, Srinivasaraghavan B, Tjoa CW, Zivadinov R. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage. 29: 505-14. PMID 16169253 DOI: 10.1016/J.Neuroimage.2005.07.053 |
0.656 |
|
| 2006 |
Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T, Balcer L. Optical coherence tomography in multiple sclerosis American Journal of Ophthalmology. 142: 1097. DOI: 10.1016/J.Ajo.2006.10.016 |
0.308 |
|
| 2005 |
Zivadinov R, Leist TP. Clinical-magnetic resonance imaging correlations in multiple sclerosis. Journal of Neuroimaging. 15. PMID 16385015 DOI: 10.1177/1051228405283291 |
0.493 |
|
| 2005 |
Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, et al. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Archives of Neurology. 62: 1519-30. PMID 16216934 DOI: 10.1001/Archneur.62.10.1519 |
0.366 |
|
| 2005 |
Benedict RH, Zivadinov R, Carone DA, Weinstock-Guttman B, Gaines J, Maggiore C, Sharma J, Tomassi MA, Bakshi R. Regional lobar atrophy predicts memory impairment in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 26: 1824-31. PMID 16091537 |
0.564 |
|
| 2005 |
Zorzon M, Zivadinov R, Locatelli L, Giuntini D, Toncic M, Bosco A, Nasuelli D, Bratina A, Tommasi MA, Rudick RA, Cazzato G. Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 12: 550-6. PMID 15958096 DOI: 10.1111/J.1468-1331.2005.00988.X |
0.428 |
|
| 2005 |
Zivadinov R. Steroids and brain atrophy in multiple sclerosis. Journal of the Neurological Sciences. 233: 73-81. PMID 15882880 DOI: 10.1016/J.Jns.2005.03.006 |
0.398 |
|
| 2005 |
Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, Weinstock-Guttman B. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of the Neurological Sciences. 231: 29-34. PMID 15792817 DOI: 10.1016/J.Jns.2004.12.009 |
0.629 |
|
| 2005 |
Zivadinov R, Sepcić J. [Cognitive impairment in multiple sclerosis patients]. Lijecnicki Vjesnik. 126: 204-10. PMID 15754791 |
0.335 |
|
| 2005 |
Zivadinov R, Grop A, Sharma J, Bratina A, Tjoa CW, Dwyer M, Zorzon M. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 15: 27-36. PMID 15574571 DOI: 10.1177/1051228404271010 |
0.373 |
|
| 2005 |
Zivadinov R, Grop A, Sharma J, Bratina A, Tjoa CW, Dwyer M, Zorzon M. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. Journal of Neuroimaging. 15: 27-36. DOI: 10.1111/J.1552-6569.2005.Tb00282.X |
0.433 |
|
| 2004 |
Locatelli L, Zivadinov R, Grop A, Zorzon M. Frontal parenchymal atrophy measures in multiple sclerosis. Multiple Sclerosis Journal. 10: 562-568. PMID 15471374 DOI: 10.1191/1352458504Ms1093Oa |
0.412 |
|
| 2004 |
Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M. Short-term brain atrophy changes in relapsing–remitting multiple sclerosis Journal of the Neurological Sciences. 223: 185-193. PMID 15337621 DOI: 10.1016/J.Jns.2004.05.010 |
0.427 |
|
| 2004 |
Sanfilipo MP, Benedict RH, Zivadinov R, Bakshi R. Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method. Neuroimage. 22: 1732-43. PMID 15275929 DOI: 10.1016/J.Neuroimage.2004.03.037 |
0.551 |
|
| 2004 |
Bagnato F, Zivadinov R, Cecchinelli D, Tancredi A, Grop A, Pierallini A, De Lena C, Prencipe M, Reale G, Zorzon M, Millefiorini E. beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 11: 455-60. PMID 15257683 DOI: 10.1111/J.1468-1331.2004.00808.X |
0.363 |
|
| 2004 |
Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis Journal of Neuroimaging. 14. PMID 15228757 |
0.393 |
|
| 2004 |
Fiotti N, Zivadinov R, Altamura N, Nasuelli D, Bratina A, Tommasi MA, Bosco A, Locatelli L, Grop A, Cazzato G, Guarnieri G, Giansante C, Zorzon M. MMP-9 microsatellite polymorphism and multiple sclerosis. Journal of Neuroimmunology. 152: 147-53. PMID 15223247 DOI: 10.1016/J.Jneuroim.2004.03.009 |
0.402 |
|
| 2004 |
Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis I: Inflammation and lesions Frontiers in Bioscience. 9: 665-683. PMID 14766399 DOI: 10.2741/1251 |
0.473 |
|
| 2004 |
Zivadinov R, Bakshi R. Role of MRI in multiple sclerosis II: Brain and spinal cord atrophy Frontiers in Bioscience. 9: 647-664. PMID 14766398 DOI: 10.2741/1262 |
0.492 |
|
| 2004 |
Zivadinov R, Bakshi R. Central nervous system atrophy and clinical status in multiple sclerosis. Journal of Neuroimaging. 14: 27-35. DOI: 10.1111/J.1552-6569.2004.Tb00276.X |
0.491 |
|
| 2003 |
Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G. Risk factors of multiple sclerosis: a case-control study. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 24: 242-7. PMID 14658040 DOI: 10.1007/S10072-003-0147-6 |
0.417 |
|
| 2003 |
Zivadinov R, Zorzon M, Tommasi MA, Nasuelli D, Bernardi M, Monti-Bragadin L, Cazzato G. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. Journal of the Neurological Sciences. 216: 113-118. PMID 14607312 DOI: 10.1016/S0022-510X(03)00225-9 |
0.341 |
|
| 2003 |
Fabiano AJ, Sharma J, Weinstock-Guttman B, Munschauer FE, Benedict RH, Zivadinov R, Bakshi R. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 13: 307-14. PMID 14569822 |
0.621 |
|
| 2003 |
Zivadinov R, Locatelli L, Stival B, Bratina A, Grop A, Nasuelli D, Brnabic-Razmilic O, Zorzon M. Normalized regional brain atrophy measurements in multiple sclerosis. Neuroradiology. 45: 793-798. PMID 14551760 DOI: 10.1007/S00234-003-1101-2 |
0.374 |
|
| 2003 |
Zivadinov R, Uxa L, Zacchi T, Nasuelli D, Ukmar M, Furlan C, Pozzi-Mucelli R, Tommasi MA, Locatelli L, Ulivi S, Bratina A, Bosco A, Grop A, Cazzato G, Zorzon M. HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis. Journal of Neurology. 250: 1099-106. PMID 14504973 DOI: 10.1007/S00415-003-0164-7 |
0.407 |
|
| 2003 |
Zivadinov R, Zorzon M, Locatelli L, Stival B, Monti F, Nasuelli D, Tommasi MA, Bratina A, Cazzato G. Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study. Journal of the Neurological Sciences. 210: 73-76. PMID 12736092 DOI: 10.1016/S0022-510X(03)00025-X |
0.392 |
|
| 2003 |
Zorzon M, Zivadinov R, Locatelli L, Stival B, Nasuelli D, Bratina A, Bosco A, Tommasi MA, Pozzi Mucelli RS, Ukmar M, Cazzato G. Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 9: 108-10. PMID 12617277 DOI: 10.1191/1352458503Ms881Sr |
0.404 |
|
| 2003 |
Zivadinov R, Iona L, Monti-Bragadin L, Bosco A, Jurjevic A, Taus C, Cazzato G, Zorzon M. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology. 22: 65-74. PMID 12566956 DOI: 10.1159/000067107 |
0.406 |
|
| 2003 |
Fabiano AJ, Sharma J, Weinstock-Guttman B, Munschauer FE, Benedict RHB, Zivadinov R, Bakshi R. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. Journal of Neuroimaging. 13: 307-314. DOI: 10.1111/J.1552-6569.2003.Tb00197.X |
0.497 |
|
| 2002 |
Zivadinov R, Zorzon M. Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. Journal of Neuroimaging. 12: 302-309. PMID 12380476 DOI: 10.1111/J.1552-6569.2002.Tb00137.X |
0.468 |
|
| 2002 |
Zorzon M, Zivadinov R, Nasuelli D, Ukmar M, Bratina A, Tommasi MA, Mucelli RP, Brnabic-Razmilic O, Grop A, Bonfigli L, Cazzato G. Depressive symptoms and MRI changes in multiple sclerosis. European Journal of Neurology. 9: 491-496. PMID 12220380 DOI: 10.1046/J.1468-1331.2002.00442.X |
0.4 |
|
| 2001 |
Zivadinov R, Rudick RA, Masi RD, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS Neurology. 57: 1239-1247. PMID 11591843 DOI: 10.1212/Wnl.57.7.1239 |
0.466 |
|
| 2001 |
Zorzon M, Zivadinov R, Bragadin LM, Moretti R, Masi RD, Nasuelli D, Cazzato G. Sexual dysfunction in multiple sclerosis: a 2-year follow-up study Journal of the Neurological Sciences. 187: 1-5. PMID 11440738 DOI: 10.1016/S0022-510X(01)00493-2 |
0.315 |
|
| 2001 |
Zorzon M, Masi Rd, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. Journal of Neurology. 248: 416-421. PMID 11437165 DOI: 10.1007/S004150170184 |
0.397 |
|
| 2001 |
Zivadinov R, Sepcic J, Nasuelli D, Masi RD, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 70: 773-780. PMID 11385012 DOI: 10.1136/Jnnp.70.6.773 |
0.453 |
|
| 2001 |
Zivadinov R, Masi RD, Nasuelli D, Bragadin LM, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology. 43: 272-278. PMID 11338408 DOI: 10.1007/S002340000500 |
0.488 |
|
| 2000 |
Zorzon M, Ukmar M, Bragadin LM, Zanier F, Antonello RM, Cazzato G, Zivadinov R. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Multiple Sclerosis Journal. 6: 386-390. PMID 11212134 DOI: 10.1177/135245850000600605 |
0.46 |
|
| 1999 |
Zorzon M, Zivadinov R, Bosco A, Bragadin LM, Moretti R, Bonfigli L, Morassi P, Iona LG, Cazzato G. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Multiple Sclerosis (Houndmills, Basingstoke, England). 5: 418-27. PMID 10618699 DOI: 10.1177/135245859900500I609 |
0.303 |
|
| 1999 |
Zivadinov R, Zorzon M, Bragadin LM, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. Journal of the Neurological Sciences. 168: 127-130. PMID 10526195 DOI: 10.1016/S0022-510X(99)00189-6 |
0.449 |
|
| Show low-probability matches. |